0001185185-12-002526.txt : 20121114 0001185185-12-002526.hdr.sgml : 20121114 20121114145120 ACCESSION NUMBER: 0001185185-12-002526 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20120930 FILED AS OF DATE: 20121114 DATE AS OF CHANGE: 20121114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PACIFIC HEALTH CARE ORGANIZATION INC CENTRAL INDEX KEY: 0001138476 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 870285238 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-50009 FILM NUMBER: 121203604 BUSINESS ADDRESS: STREET 1: 1201 DOVE STREET STREET 2: SUITE 300 CITY: NEWPORT BEACH STATE: CA ZIP: 92260 BUSINESS PHONE: (949) 721-8272 MAIL ADDRESS: STREET 1: 1201 DOVE STREET STREET 2: SUITE 300 CITY: NEWPORT BEACH STATE: CA ZIP: 92260 10-Q 1 pacifichealth10q093012.htm pacifichealth10q093012.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 


FORM 10-Q
 

 
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the Quarterly Period Ended September 30, 2012

o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the Transition Period From ________ to _________

Commission File Number 000-50009

PACIFIC HEALTH CARE ORGANIZATION, INC.
(Exact name of registrant as specified in its charter)

Utah
 
87-0285238
(State or other jurisdiction of
 
(I.R.S. Employer
incorporation or organization)
 
Identification No.)
     
1201 Dove Street, Suite 300
   
Newport Beach, California
 
92660
(Address of principal executive offices)
 
(Zip Code)

(949) 721-8272
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for any shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.    Yes x   No o
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files.)      
Yes x   No o
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer o  
Accelerated filer o
Non-accelerated filer (Do not check if a smaller reporting company) o
Smaller reporting company x
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.)  Yes o    No x

 As of November 9, 2012, the registrant had 802,424 shares of common stock, par value $0.001, issued and outstanding.
 
 
PACIFIC HEALTH CARE ORGANIZATION, INC.
FORM 10-Q
TABLE OF CONTENTS
 
 
Page
   
PART I — FINANCIAL INFORMATION
 
   
3
     
 
3
     
 
4
     
 
5
     
 
6
   
7
   
16
   
16
   
PART II — OTHER INFORMATION
 
   
17
   
17
   
18


PART I.   FINANCIAL INFORMATION

Item 1.   Financial Information
Pacific Health Care Organization, Inc.
Condensed Consolidated Balance Sheets
 
   
September 30, 2012
(Unaudited)
   
December 31,
2011
 
ASSETS            
Current Assets
           
    Cash
 
$
407,754
   
$
368,459
 
    Accounts receivable, net of allowance of $20,000
   
1,359,467
     
523,864
 
    Income tax receivable
   
3,998
     
3,998
 
    Prepaid income tax
   
61,511
     
-
 
    Commission draw
   
503
     
29,853
 
    Prepaid expenses
   
49,127
     
53,947
 
Total current assets
   
1,882,360
     
980,121
 
                 
Property and equipment, net
               
    Computer equipment
   
106,732
     
80,963
 
    Furniture & fixtures
   
80,230
     
56,471
 
    Office equipment
   
26,560
     
12,537
 
    Office equipment under capital lease
   
25,543
     
25,543
 
   Total property & equipment
   
239,065
     
175,514
 
   Less: accumulated depreciation and amortization
   
(123,898
)
   
(104,294
)
    Net property & equipment
   
115,167
     
71,220
 
                 
Other assets
   
8,158
     
8,158
 
   Total assets
 
$
2,005,685
   
$
1,059,499
 
                 
LIABILITIES AND STOCKHOLDERS' EQUITY
               
                 
Current Liabilities
               
    Accounts payable
 
$
32,769
   
$
86,482
 
    Accrued expenses
   
240,216
     
126,770
 
    Income tax payable
   
363,555
     
1,611
 
    Current obligation under capital lease
   
6,947
     
6,592
 
    Deferred rent expense
   
25,032
     
21,903
 
    Deferred tax liability
   
5,404
     
5,404
 
    Unearned revenue
   
4,757
     
7,803
 
Total current liabilities
   
678,680
     
256,565
 
                 
Long term liabilities
               
   Noncurrent obligation under capital lease
   
1,814
     
7,069
 
    Total liabilities
   
680,494
     
263,634
 
                 
Commitments and Contingencies
   
-
     
-
 
                 
Shareholders’ Equity
               
    Preferred stock; 5,000,000 shares authorized at $0.001 par value; zero shares issued and outstanding
      -
 
   
-
 
    Common stock; 50,000,000 shares authorized at $0.001 par value; 802,424 shares issued and outstanding
   
802
     
802
 
    Additional paid-in capital
   
623,629
     
623,629
 
    Retained earnings (deficit)
   
700,760
     
171,434
 
Total stockholders' equity
   
1,325,191
     
795,865
 
Total liabilities and stockholders’ equity
 
$
2,005,685
   
$
1,059,499
 
 
The accompanying notes are an integral part of these consolidated financial statements. 
 
 
Pacific Health Care Organization, Inc.
Condensed Consolidated Statements of Operations
(Unaudited)
 
   
For three months ended
September 30,
   
For nine months ended
September 30,
 
   
2012
   
2011
   
2012
   
2011
 
                         
Revenues:
                       
   HCO fees
 
$
301,077
   
$
205,362
   
$
691,574
   
$
565,831
 
   MPN fees
   
205,238
     
171,092
     
569,584
     
455,761
 
   Other
   
820,486
     
487,943
     
2,255,011
     
1,006,308
 
   Total revenues
   
1,326,801
     
864,397
     
3,516,169
     
2,027,900
 
                                 
Expenses:
                               
   Depreciation & amortization
   
7,153
     
3,903
     
19,605
     
9,691
 
   Consulting fees
   
143,326
     
93,946
     
354,019
     
279,173
 
   Salaries & wages
   
440,890
     
363,206
     
1,236,088
     
791,842
 
   Professional fees
   
77,558
     
49,428
     
195,833
     
146,380
 
   Insurance
   
54,854
     
40,766
     
152,761
     
107,947
 
   Outsource service fees
   
114,550
     
57,199
     
259,972
     
120,825
 
   Data maintenance
   
31,285
     
19,370
     
51,969
     
36,463
 
   General & administrative
   
143,285
     
107,987
     
356,349
     
301,512
 
   Total expenses
   
1,012,901
     
735,805
     
2,626,596
     
1,793,833
 
                                 
Income from operations
   
313,900
     
128,592
     
889,573
     
234,067
 
                                 
Other income (expense):
                               
   Loss on disposal of assets
   
-
     
-
     
-
     
(1,564
   Interest income
   
170
     
                224
     
551
     
760
 
   Rental income
   
250
     
-
     
1,750
     
 
 
   Interest (expense)
   
(173
)    
(285
)
   
(604
   
(934
   Total other income (expense)
   
247
     
(61
   
1,697
     
(1,738
                                 
Income before taxes
   
314,147
     
            128,531
     
891,270
     
232,329
 
                                 
   Income tax provision
   
127,574
     
53,671
     
361,944
     
85,182
 
                                 
   Net income
 
$
186,573
   
$
74,860
   
$
529,326
   
$
147,147
 
                                 
Basic and fully diluted earnings per share:
                               
   Earnings per share amount
 
$
.23
   
$
                 .09
   
$
.66
   
$
.18
 
   Weighted average common shares outstanding
   
802,424
     
802,424
     
802,424
     
802,424
 

The accompanying notes are an integral part of these consolidated financial statements.
 
 
Pacific Health Care Organization, Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
 
   
Nine months ended
September 30,
 
   
2012
   
2011
 
Cash flows from operating activities:
           
       Net income
 
$
529,326
   
$
147,147
 
Adjustments to reconcile net income to net cash:
               
   Depreciation and amortization
   
19,604
     
9,691
 
   Loss on disposition of assets
   
-
     
1,564
 
Changes in operating assets & liabilities
               
   (Increase) in accounts receivable
   
(835,603
)    
(274,120
   Decrease in deferred tax asset
   
-
     
5,400
 
   (Increase) in prepaid income tax
   
(61,511
   
(108,800
)
   Decrease in income tax receivable
   
-
     
35,100
 
   Decrease (increase) in commission draw
   
29,350
     
   (5,760
   Decrease in prepaid expenses
   
4,820
     
26,203
 
   (Decrease) increase in accounts payable
   
(53,713
)    
30,714
 
   Increase in accrued expenses
   
113,446
     
91,969
 
   Increase in income tax payable
   
361,944
     
84,854
 
   Increase in deferred rent expense
   
3,129
     
18,414
 
   (Decrease) in unearned revenue
   
(3,046
   
(4,720
)
           Net cash provided by operating activities
   
107,746
     
57,656
 
                 
Cash flows from investing activities
               
   Purchases of furniture & equipment
   
(63,551
   
(50,443
       Net cash used by investing activities
   
(63,551
   
(50,443
                 
Cash flows from financing activities
               
        Payment of obligation under capital lease
   
(4,900
   
(4,570
           Net cash provided by (used in) financing activities
   
(4,900
)    
   (4,570
             Increase in cash
   
39,295
     
2,643
 
             Cash at beginning of period
   
368,459
     
349,552
 
             Cash at end of period
 
$
407,754
   
$
352,195
 
Supplemental Cash Flow Information
               
   Cash paid (refunded) for:
               
             Interest
 
$
604
   
$
649
 
             Taxes refunded
 
$
  -
 
 
$
(38,718
             Taxes paid
 
$
61,511
   
$
107,346
 

The accompanying notes are an integral part of these consolidated financial statements.
 
 
Pacific Health Care Organization, Inc.
Notes to Condensed Consolidated Financial Statements
For the Nine Months Ended September 30, 2012
 
NOTE 1 – BASIS OF FINANCIAL STATEMENT PRESENTATION

The accompanying unaudited condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”).  Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted in accordance with such rules and regulations.  The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements.  Although management believes the disclosures and information presented are adequate to make the information not misleading, it is suggested that these interim condensed financial statements be read in conjunction with the Company’s audited financial statements and notes thereto included in its Annual Report on Form 10-K for the year ended December 31, 2011.  Operating results for the nine-months ended September 30, 2012 are not necessarily indicative of the results to be expected for the year ending December 31, 2012.

NOTE 2 – SUBSEQUENT EVENTS

In accordance with ASC 855-10 Company management reviewed all material events through the date of issuance and there are no material subsequent events to report.
 
 
Item 2.   Management’s Discussion and Analysis of Financial Statements and Results of Operations

This quarterly report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended, that are based on our management’s beliefs and assumptions and on information currently available to our management.  For this purpose any statement contained in this report that is not a statement of historical fact may be deemed to be forward-looking, including statements about our revenue, spending, cash flow, products, actions, intentions, plans, strategies and objectives.  Without limiting the foregoing, words such as “may,” “hope,” “will,” “expect,” “believe,” “anticipate,” “estimate” “projected” or “continue” or comparable terminology are intended to identify forward-looking statements.  These statements by their nature involve substantial risks and uncertainty, and actual results may differ materially depending on a variety of factors, many of which are not within our control.  These factors include but are not limited to economic conditions generally and in the industry in which we and our customers participate; competition within our industry, including competition from much larger competitors; legislative requirements or changes which could render our services less competitive or obsolete; our failure to successfully develop new services and/or products or to anticipate current or prospective customers’ needs; price increases or employee limitations; and delays, reductions, or cancellations of contracts we have previously entered.

Forward-looking statements are predictions and not guarantees of future performance or events.  The forward-looking statements are based on current industry, financial and economic information, which we have assessed but which by its nature, is dynamic and subject to rapid and possibly abrupt changes.  Our actual results could differ materially from those stated or implied by such forward-looking statements due to risks and uncertainties associated with our business.  We hereby qualify all our forward-looking statements by these cautionary statements. We undertake no obligation to amend this report or revise publicly these forward looking statements (other than pursuant to reporting obligations imposed on registrants pursuant to the Securities Exchange Act of 1934) to reflect subsequent events or circumstances.

The following discussion should be read in conjunction with our financial statements and the related notes contained elsewhere in this report and in our other filings with the Securities and Exchange Commission.

Throughout this quarterly report on Form 10-Q, unless the context indicates otherwise, the terms, “we,” “us,” “our” or “the Company” refer to Pacific Health Care Organization, Inc., (“PHCO”) and our wholly-owned subsidiaries Medex Healthcare, Inc. (“Medex”), Industrial Resolutions Coalition, Inc. (“IRC”), Medex Managed Care, Inc. (“MMC”), Medex Legal Support, Inc., (“MLS”) and Medex Medical Management, Inc.  (“MMM”).

Overview

Through our subsidiary Medex, we engage in the business of managing and administering Health Care Organizations (“HCOs”) and Medical Provider Networks (“MPNs”) in the state of California. For many years, workers’ compensation costs in California have been high. Under the traditional model of workers’ compensation insurance coverage, the employer controls the selection of the medical provider for the first 30 days after the injury is reported.  Thereafter the employee chooses the treating physician and the employer has no further control over the treatment of the patient. Since 1993, the legislature in California has enacted various laws designed to introduce alternatives to the traditional model of workers’ compensation aimed at controlling costs by giving employers greater control over the medical treatment of injured workers for a longer period of time.

In 1993 the California legislature passed a bill that established Health Care Organizations.  An HCO is a network of health care professionals specializing in the treatment of workplace injuries and in back-to-work rehabilitation and training.  The benefit of the HCO to an employer is two-fold.  First, the employer is able to control the medical treatment of the injured employee for 90 to 180 days rather than during just the first 30 days.  Second, the HCO provides the employer a network of trained providers to which it can refer its injured employees who specialize in treating work place injuries.
 
 
Under the HCO guidelines, all HCOs are required to pay certain annual fees to the California Division of Workers’ Compensation (“DWC”).  This annual fee is based on the number of employees enrolled in the HCO.

In 2004 the California legislature enacted laws that created MPNs.  Like an HCO, an MPN is a network of health care professionals, but MPN networks are not required to have the same level of medical expertise in treating employee work place injuries.  Under an MPN program, the employer dictates which physician the injured employee will see for the initial visit.  Thereafter, the employee can choose to treat with any physician within the MPN network.

By virtue of our continued certification as an HCO, we were statutorily deemed to be qualified as an approved MPN.  As a licensed HCO and MPN, we are able to offer our clients an HCO program, an MPN program and a combination of the HCO and MPN programs.  Under this combination model, an employer can enroll its employees in the HCO program then, prior to the expiration of the 90 or 180 day treatment period under the HCO program, the employer can enroll the employee into the MPN program.  This allows employers to take advantage of both programs.  To our knowledge, we are currently the only entity that offers both programs together.

Through our wholly-owned subsidiary IRC we participate in the business of creating legal agreements for the implementation and administration of Carve-Outs for California employers with collective bargaining units.

Our wholly-owned subsidiary MMC oversees and manages our utilization review (“UR”) and medical bill review (“MBR”).   Through our wholly-owned subsidiaries MLS and MMM we offer lien representation services and nurse case management (“NCM”) services, respectively.

Results of Operations

Comparison of the three months ended September 30, 2012 and 2011

Revenue

The total number of employee enrollees increased 27% during three months ended September 30, 2012 compared to September 30, 2011.  Total revenues increased 53% to $1,326,801.  As of September 30, 2012, we had approximately 442,000 total enrollees.  Enrollment consisted of approximately 76,000 HCO enrollees and 366,000 MPN enrollees.  By comparison as of September 30, 2011 we had approximately 348,000 total enrollees, including approximately 55,000 HCO enrollees and approximately 293,000 MPN enrollees.

The net increase in HCO and MPN enrollees of approximately 21,000 and 73,000, respectively from September 30, 2011 to September 30, 2012, was mainly the result of increased enrollment realized by our existing customers and the addition of four new HCO customers and three new MPN customers.  Even through HCO revenues increased approximately 47%, compared to the quarter ended September 30, 2011, HCO enrollment only increased by 38%.  By comparison, MPN revenues increased by 20% and enrollment increased by 25%.  While the economic slowdown impacted our revenue throughout fiscal 2011, we anticipate HCO and MPN revenues will continue to be slightly higher during the fourth quarter of fiscal 2012.
 

In the current economic environment, we anticipate businesses will continue to seek ways to reduce their workers’ compensation program costs.  As a result, we expect to experience client turnover, in the form of existing employer clients seeking to terminate or renegotiate the scope and terms of existing services.  We also anticipate our market may shrink as some employers seek to reduce their costs by managing their workers’ compensation care services in-house.  In response to the changing market, we have sought to expand our marketing efforts for some of the additional services we now offer our clients.  As a result, during the quarter ended September 30, 2012, we realized increases in our MBR and UR services fee revenues.

HCO Fees

During the three months ended September 30, 2012 and 2011, HCO fee revenues were $301,077 and $205,362, respectively.  While HCO enrollment increased 38% during the quarter ended September 30, 2012, we realized a 47% increase in revenue from HCO fees when compared to the same period last year.  The percentage increase in revenues outpaced the percentage increase in enrollment by 8%.  This was the result of an increase in the volume of claims network fees to a number of new clients which resulted in increased revenues.  We expect HCO revenues in the fourth quarter of 2012 to be slightly higher when compared to the quarter ended September 30, 2012 resulting mainly from increased network claims fees and network access fees.

MPN Fees

MPN Fee revenues for the three months ended September 30, 2012 were $205,238 compared to $171,092 for the three months ended September 30, 2011.  During the quarter ended September 30, 2012 we realized a 25% increase in MPN enrollment when compared the same period 2011 and a corresponding 20% increase in revenues.  Although MPN enrollment increased 25%, MPN revenues increased by only 20% because of differing fee terms, unbundling of services, price competition and similar factors during the three months ended September 30, 2012. MPN fee revenue for the fourth quarter of fiscal 2012 is expected to increase over the 3rd quarter 2012 due to increases in MPN enrollment.

Other Fees

Other fees consist of revenues derived from MBR, NCM, UR, lien representation services and network claims repricing services provided by Medex, MMC, MMM and MLS. Other fee revenues for the three months ended September 30, 2012 and 2011 were $820,486 and $487,943, respectively.

Our MBR and UR revenues increased by $82,436 and $70,786 during the third fiscal quarter 2012, respectively, when compared to the same period of fiscal 2011.  MBR and UR service revenues grew largely as a result of increased marketing efforts by MMC in these areas of our business.  We expect MBR and UR revenues for the fourth quarter of 2012 to remain constant when compared to the third quarter of 2012 resulting from lower levels of hospital PPO fees offset by higher employee enrollment when compared to the third quarter of 2012.

NCM revenues increased $113,394 to $220,371 primarily as a result of increased customer employee enrollment. We retain nurses on our staff who, at the request of our customers, will review the medical portion of a claim on behalf of our employer clients, claims managers and injured workers.  We offer nurse case management services to our customers on an optional basis.  We charge an additional fee for nurse case management services. NCM revenues for the fourth quarter of 2012 is expected to remain constant when compared to the third quarter of 2012 due to decreased revenue expected from one customer and increased estimated revenue from two new customers.

Our network claims repricing fees are generated from certain customers’ split cost savings generated from their PPO.  Network claims repricing fees increased from $20,668 during the three months ended September 30, 2011 to $62,160 during the three months ended September 30, 2012 resulting primarily from the addition of two new customers during the fourth quarter 2011.
 

We commenced offering lien representation services in February 2012 and recorded revenues totaling $24,434 for the quarter ended September 30, 2012.

Expenses

Total expenses for the three months ended September 30, 2012 and 2011 were $1,012,901 and $735,805, respectively.  The increase of $277,096 was the result of increases in all expense categories averaging an increase of 38%.

Consulting Fees,

During the three months ended September 30, 2012, consulting fees increased to $143,326 from $93,946 during the three months ended September 30, 2011.  This increase of $49,380 was mainly due to higher fees incurred in connection with replacing our information technology firm in January 2012 and June 2012, together with the addition of three temporary administrative staff consultants.

Additionally, in the event we see an increased level of services requested from our customers, especially for nurse case management services which would require us to engage additional nurse case managers, we could experience higher consulting fees.

Salaries and Wages

Salaries and wages increased $77,684 or 21% to $440,890 during the three months ended September 30, 2012 compared with the three months ended September 30, 2011.  The increase in salaries and wages was primarily due to MMC hiring one MBR administrator in January 2012 and Medex hiring a nurse case manager in October 2011, and administrative support personnel in November and December of 2011 and three temporary support personnel in June 2012. The Senior Vice President of Medex was promoted to COO effective September 1, 2012 and received an increase in annual salary in connection with this promotion.  In addition, the CEO and CFO of PHCO received an increase in their annual salaries in September 2012 and the CEO was paid a bonus/vacation payment in July 2012.

Professional Fees

For the three months ended September 30, 2012, we incurred professional fees of $77,558, compared to $49,428 during the three months ended September 30, 2011.  This 57% increase in fees was primarily attributable to an increase in requests for the assignment of professional field case management nurses. These contracted nurses attend medical appointments on behalf of MMM. These invoiced fees are marked up by MMM and billed to each customer. Increased accounting fees in connection with preparing our financial reports also contributed to this increase.

Insurance

During the three months ended September 30, 2012, we incurred insurance expenses of $54,854, a $14,088 increase over the prior year three-month period.  The increase in 2012 was due to premium increases for our employee group health medical coverage resulting from the increase in our total number of employees and increased premiums for our workers’ compensation insurance. We are currently reviewing all of our company insurance policies and do not expect a material increase during the remainder of this fiscal year.
 

Outsource Service Fees

Outsource service fees consist of costs incurred by MMC, Medex and MMM in outsourcing its MBR services and certain NCM and UR services.  We do not, at this time, have enough volume to justify creating our own MBR and UR in-house staff.  We utilize outside vendors to provide specific services for our clients, charging additional fees over and above those paid to vendors for administration and coordination of MBR, NCM and UR services directly to the clients. We incurred $114,550 and $57,199 in outsource service fees during the three month periods ended September 30, 2012 and 2011, respectively. This $57,351 increase was primarily the result of the increased demand for our MBR, UR and NCM services.

Data Maintenance

During the three months period ended September 30, 2012 we experienced a 62% increase in data maintenance fees.  The increase in data maintenance fees was primarily attributable to increased data maintenance costs associated with the increase in MPN and HCO enrollees.

General and Administrative
 
During the three months ended September 30, 2012, we incurred general and administrative expenses of $143,285 a $35,298 increase over the prior year three-month period.  The increase in 2012 was primarily the result of higher rent expenses incurred by leasing addition space during January 2012, vacation expense and internet expenses.

Net Income

During the three months ended September 30, 2012, total revenues of $1,326,801 were higher by $462,404 when compared to the same period in 2011.  This increase in total revenues was partially offset by increases in total expenses of $277,096 resulting in income from operations of $313,900 compared to income from operations of $128,592 during three months ended September 30, 2011.  Correspondingly, we realized net income of $186,573 for the three months ended September 30, 2012, compared to net income of $74,860, during the three months ended September 30, 2011.  We believe revenue growth in the fourth quarter will level off and starting first quarter of 2013, we expect moderate revenues increases to be generated from new services offered by the Company to existing and new customers in the areas of MBR, clinical and non-clinical UR, and other services.

Comparison of the nine months ended September 30, 2012 and 2011

Revenue

The total number of employee enrollees increased 27% during nine months ended September 30, 2012 compared to September 30, 2011.  Total revenues increased 73% to $3,516,169.

The net increase in HCO and MPN enrollees of approximately 21,000 and 73,000, respectively, was mainly the result of adding four major HCO customers and three major MPN customers.  During the nine months ended September 30, 2012, we have also been able to increase our MBR and UR services revenues.

HCO Fees

During the nine months ended September 30, 2012 and 2011 HCO fee revenues were $691,574 and $565,831 respectively.  As noted above, while HCO enrollment increased 38% during the nine months ended September 30, 2012, we realized a 22% increase in revenue from HCO fees when compared to the same period last year.  The percentage increase in enrollment outpaced the percentage increase in revenue by 16%.   Although HCO enrollment increased 38%, HCO revenues increased by only 22% because of lower monthly HCO fees, unbundling of services, price competition and similar factors, partially offset by higher claims network fees and increased enrollment during the three months ended September 30, 2012.
 

MPN Fees

MPN Fee revenues for the nine months ended September 30, 2012 were $569,584 compared to $455,761 for the nine months ended September 30, 2011.  We had an increase in MPN enrollment of 25% during the nine months ended September 30, 2012, as noted above, which resulted in a 22% increase in MPN revenues compared to the same period 2011.

Other Fees

As mentioned above other fees consist of revenues derived from MBR, NCM, UR, lien representation services and network claims repricing services provided by Medex, MMC, MMM and MLS. Other fee revenues for the nine months ended September 30, 2012 and 2011 were $2,255,011 and $1,006,308, respectively.

During the nine months ended September 30, 2012, MBR and UR revenues increased by $454,936 and $344,961, respectively, when compared to the same period of fiscal 2011.  MBR and UR service revenues grew largely as a result of increased marketing efforts by MMC in these areas of our business.

During the nine months ended September 30, 2012 and 2011, NCM revenue was $517,777 and $259,388, respectively. This increase of $258,389 was primarily the result of increased customer employee enrollment.

We commenced offering lien representation services in February 2012 and have recorded revenues totaling $46,720 for the nine month period ended September 30, 2012.  We did not offer such services during the nine months ended September 30, 2011.

During the nine months period ended September 30, 2012 and 2011, network claims repricing fees were $198,849 and $55,152, respectively.

Expenses

Total expenses for the nine months ended September 30, 2012 and 2011 were $2,626,596 and $1,793,833, respectively. The increase of $832,763 was the primarily the result of increases in consulting fees, depreciation, outsource service fees, salaries and wages, professional fees, insurance, data maintenance and general and administrative expense.

Consulting Fees

During the nine months ended September 30, 2012, consulting fees increased to $354,019 from $279,173 during the nine months ended September 30, 2011.  This increase in consulting fees of $74,846 was due mainly to the addition of a temporary administrative consultant during January 2012 and the incurring of increased consulting fees in connection with replacing our information technology firm in January 2012 and June 2012, together with the addition of three temporary administrative staff consultants in the third quarter of 2012.
 
 
Salaries and Wages

Salaries and wages increased $444,246 or 56% to $1,236,088 during the nine months ended September 30, 2012 compared with the nine months ended September 30, 2011.  The increase in salaries and wages was primarily due to MMC hiring one MBR administrator in January 2012 and Medex hiring a nurse case manager in October 2011, an administrative support personnel in July, November and December of 2011 and three temporary support personnel in June 2012. The Senior Vice President of Medex was promoted to COO effective September 1, 2012 and received an increase in annual salary in connection with this promotion.  In addition, the CEO and CFO of PHCO received in September 2012, an increase in their annual salaries and the CEO was paid a bonus/vacation payment in July 2012.

Professional Fees

For the nine months ended September 30, 2012, we incurred professional fees of $195,833 compared to $146,380 during the nine months ended September 30, 2011.  This 34% increase in professional fees was primarily attributable to an increase in requests for the assignment of professional field case management nurses. These contracted nurses attend medical appointments on behalf of MMM. These invoiced fees are marked up by MMM and billed to each customer. Increased accounting fees in connection with preparing our financial reports also contributed to this increase.

Insurance

During the nine months ended September 30, 2012, we incurred insurance expenses of $152,761 an increase of $44,814 over the same nine-month period of 2011. The increase in 2012 was primarily due to premium increases for our employee group health medical coverage resulting from the increase in our total number of employees and increased premiums for our workers’ compensation insurance. We are currently reviewing all of company insurance policies and do not expect a material increase during the remainder of this fiscal year.

Outsource Service Fees

As discussed above, outsource service fees consist of costs incurred by our subsidiaries in outsourcing its MBR services and certain NCM and UR services.  We incurred $259,972 and $120,825 in outsource service fees during the nine month periods ended September 30, 2012 and 2011, respectively

Data Maintenance

During the nine months ended September 30, 2012, we incurred a 42% increase in data maintenance fees.  The increase in data maintenance fees was primarily attributable to increased data maintenance costs associated with the increase in MPN and HCO enrollees.

General and Administrative
 
General and administrative expenses increased 18% to $356,349 during the nine months ended September 30, 2012.  The increase in general and administrative expense was primarily attributable to increases in internet expense, license and permits, office supplies, postage expense and rent expense partially offset with decreases in dues and subscriptions, employment agency fees, equipment repairs, moving expense and telephone expense. Provided we continue to add new customers at our current rate, we expect current levels of general and administrative expenses to increase during the remainder of this fiscal year. 
 

Net Income

We realized net income of $529,326 for the nine months ended September 30, 2012 compared to a net income of $147,147, during the nine months ended September 30, 2011.  We expect moderate increases in revenues to continue in the nine-month period ending September 30, 2012, when compared to the corresponding nine-month period of 2011, to be generated primarily from new services offered by the Company to our existing and new customers in the areas of MBR and clinical and non-clinical UR and other services.

Liquidity and Capital Resources

           As of September 30, 2012, we had cash on hand of $407,754 compared to $368,459 at December 31, 2011.  The $39,295 increase in cash on hand is primarily the result of increases in our net profit, depreciation, accrued expense and income tax payable and decreases in commission draw and prepaid expenses, which were partially offset by increases in account receivables and prepaid taxes, a decrease in accounts payable and the purchase of furniture and equipment.  We believe that cash on hand and anticipated revenues from operations will be sufficient to cover our operating costs over the next twelve months.  We do not anticipate needing to find other sources of capital at this time. However, if our revenue is lower than anticipated we may need to find other sources of capital to fund operations.

We currently have budgeted approximately $55,000 for capital expenditures planned for the fourth quarter of this year and do not anticipate needing to seek outside sources of funding during the remainder of the current year.  We do, however, from time to time, investigate potential opportunities to expand our business either through the creation of new business lines or the acquisition of existing businesses.  We have not identified any suitable opportunity at the current time.  An expansion or acquisition of this sort may require greater capital resources than we possess.  Should we need additional capital resources, we most likely would seek to obtain such through debt and/or equity financing.  We do not currently possess an institutional source of financing.  Given current credit conditions, there is no assurance that we could be successful in obtaining additional debt financing on favorable terms, or at all.  Similarly, given current market and economic conditions there is no guarantee that we could negotiate appropriate equity financing.

Cash Flow

During the nine months ended September 30, 2012 cash was primarily used to fund operations. We had a net increase in cash of $39,295 during the nine months ended September 30, 2012.  See below for additional discussion and analysis of cash flow.

   
For the nine months ended
September 30,
 
   
2012
(unaudited)
   
2011
(unaudited)
 
             
Net cash provided by operating activities
 
$
107,746
   
$
57,656
 
Net cash used in investing activities
   
(63,551)
     
 (50,443
)
Net cash used in financing activities
   
(4,900
   
(4,570
                 
Net Change in Cash
 
$
39,295
   
$
          2,643
 

During the nine months ended September 30, 2012 net cash provided by operating activities was $107,746, compared to net cash provided by operating activities of $57,656 during the nine months ended September 30, 2011.  As discussed herein we realized net income of $529,326 during the nine months ended September 30, 2012, compared to net income of $147,147 during the nine months ended September 30, 2011.
 

Summary of Material Contractual Commitments
 
The following is a summary of our material contractual commitments as of September 30, 2012:
 
   
Payments Due By Period
 
Contractual obligations
 
Total
   
Less than 1 year
   
1-3 years
   
3-5 years
   
More than
5 years
 
                               
Equipment Leases(1)
 
$
13,447
   
$
2,521
   
$
10,926
   
$
-
   
$
-
 
Office Leases(2)
   
491,784
     
34,234
     
432,800
     
24,750
     
-
 
Total
 
$
505,231
   
$
36,755
   
$
443,726
   
$
24,750
   
$
-
 

 
(1)
 
In January 2010 we entered into a capital lease arrangement whereby we leased an office copy machine for $25,543. The asset was recorded on our balance sheet under office equipment under capital lease and our liability incurred under the lease was recorded as current and noncurrent obligations under capital lease.  The lease arrangement is for a term of 48 months at level operating rents with capital interest rate at 7%.

 
(2)
On March 1, 2011 we commenced a new office lease agreement that runs to February 29, 2016.  Unlike our previous arrangements, the new office space is sufficient for PHCO and each of our subsidiaries. Following is our annual base rent for the new office space throughout the term of the lease:

Rent Period
 
Annual Rent Payments
 
Oct.  1 to Dec. 31, 2012
 
$
34,234
 
Jan. 1 to Dec. 31, 2013
 
$
140,342
 
Jan. 1 to Dec. 31, 2014
 
$
144,508
 
Jan. 1 to Dec. 31, 2015
 
$
147,950
 
Jan. 1 to Feb. 29, 2016
 
$
24,750
 
    Total
 
$
491,784
 

Off-Balance Sheet Financing Arrangements

As of September 30, 2012 we had no off-balance sheet financing arrangements.

Critical Accounting Policies and Estimates

The preparation of financial statements in accordance with accounting standards generally accepted in the United States requires management to make estimates and assumptions that affect both the recorded values of assets and liabilities at the date of the financial statements and the revenues recognized and expenses incurred during the reporting period. Our estimates and assumptions affect our recognition of deferred expenses, bad debts, income taxes, the carrying value of its long-lived assets and its provision for certain contingencies. We evaluate the reasonableness of these estimates and assumptions continually based on a combination of historical information and other information that comes to its attention that may vary its outlook for the future. Actual results may differ from these estimates under different assumptions.
 
We believe the critical accounting policies that most impact our consolidated financial statements are described below.

Basis of Accounting We use the accrual method of accounting.
 

Revenue Recognition —  The Company applies the revenue recognition provisions pursuant to Accounting Standards Codification (“ASC”) 605.10, Revenue Recognition (“ASC 605”) (formerly SAB Topic 13A), which provides guidance on the recognition, presentation and disclosure of revenue in financial statements filed with the SEC.  The guidance outlines the basic criteria that must be met to recognize the revenue and provides guidance for disclosure related to revenue recognition policies.

In general, the Company recognizes revenue related to licensing fees on a monthly basis, over the life of the licensing agreement, and when (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred or services have been rendered, (iii) the fee is fixed or determinable and (iv) collectability is reasonably assured.

Health care service revenues are recognized in the period in which fees are fixed or determinable and the related services are provided to the subscriber.

Certain HCO and MPN subscribers  pay in advance for their services by check for billings made in advance, revenue is then recognized ratably over the period in which the related services are provided.  Advance payments from subscribers and billings made in advance are recorded on the balance sheet as deferred revenue.  An allowance for uncollectible accounts is established for any customer who is deemed as possibly uncollectible.

Health care service revenues generally are recognized in the period in which fees are fixed or determinable and the related services are provided to the subscriber.

Principles of Consolidation — The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries.  Intercompany transactions and balances have been eliminated in consolidation.

Item 3.  Quantitative and Qualitative Disclosure about Market Risk

As a smaller reporting company as defined in Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and in Item 10(f)(1) of Regulation S-K, we are electing scaled disclosure reporting obligations and therefore are not required to provide the information requested by this Item.
 
Item 4.   Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) under the Exchange Act), as of the end of the period covered by this quarterly report on Form 10-Q.  Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that as of the end of the period covered by this quarterly report on Form 10-Q, our disclosure controls and procedures were effective in (1) recording, processing, summarizing and reporting, information required to be disclosed by us in the reports that we file or submit under the Exchange Act within the time periods specified in the SEC’s rules and forms and (2) ensuring that information disclosed by us in such reports is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended September 30, 2012 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
 

PART II.   OTHER INFORMATION
 
Item 1A.  Risk Factors

As a smaller reporting company as defined in Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and in Item 10(f)(1) of Regulation S-K, we are electing scaled disclosure reporting obligations and therefore are not required to provide the information requested by this Item.
 
Item 6.   Exhibits

 Exhibits.  The following exhibits are included as part of this Quarterly Report:

 
Exhibit Number
 
Title of Document
       
 
Exhibit 31.1
 
       
 
Exhibit 31.2
 
       
 
Exhibit 32.1
 
       
 
Exhibit 32.2
 
       
 
Exhibit 101.INS
 
XBRL Instance Document
       
 
Exhibit 101.SCH
 
XBRL Taxonomy Extension Schema Document
       
 
Exhibit 101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document
       
 
Exhibit 101.DEF
 
XBRL Taxonomy Definition Linkbase Document
       
 
Exhibit 101.LAB
 
XBRL Taxonomy Extension Label Linkbase Document
       
 
Exhibit 101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

   
PACIFIC HEALTH CARE ORGANIZATION, INC.
       
       
Date:
November 14, 2012
/s/ Tom Kubota  
   
Tom Kubota
Chief Executive Officer
 

       
Date:
November 14, 2012
/s/ Fred Odaka  
   
Fred Odaka
Chief Financial Officer
 
 
EX-31.1 2 ex31-1.htm ex31-1.htm
EXHIBIT 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Tom Kubota, certify that:

1)  I have reviewed this quarterly report on Form 10-Q of Pacific Health Care Organization, Inc.

2)  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3)  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of registrant as of, and for, the periods presented in this report;

4)  The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:

(a) Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal controls over financial reporting; and

5)  The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.



Date:  November 14, 2012                                      By:       /s/ Tom Kubota                                                                                                 
Tom Kubota
Chief Executive Officer
EX-31.2 3 ex31-2.htm ex31-2.htm
EXHIBIT 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Fred Odaka, certify that:

1)  I have reviewed this quarterly report on Form 10-Q of Pacific Health Care Organization, Inc.

2)  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3)  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of registrant as of, and for, the periods presented in this report;

4) The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:

(a) Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal controls over financial reporting; and

5)  The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.



Date: November 14, 2012                                     By:         /s/ Fred Odaka                                                                                       
Fred Odaka
Chief Financial Officer
EX-32.1 4 ex32-1.htm ex32-1.htm
EXHIBIT 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT BY
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the quarterly report on Form 10-Q of Pacific Health Care Organization, Inc. (the “Company”) for the three months ended September 30, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Tom Kubota, Chief Executive Officer of Pacific Health Care Organization, Inc., certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1) The Report fully complies with the requirements of section 13 (a) or 15 (d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.


 
Date: November 14, 2012                                                                     /s/ Tom Kubota                                                  
 Tom Kubota
 Chief Executive Officer
 
EX-32.2 5 ex32-2.htm ex32-2.htm
EXHIBIT 32.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT BY
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the quarterly report on Form 10-Q of Pacific Health Care Organization, Inc. (the “Company”) for the three months ended September 30, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Fred Odaka, Chief Financial Officer of Pacific Health Care Organization, Inc., certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1) the Report fully complies with the requirements of section 13 (a) or 15 (d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.



Date: November 14, 2012                                                            /s/ Fred Odaka                                           
Fred Odaka
Chief Financial Officer
EX-101.INS 6 pfho-20120930.xml 0001138476 2012-09-30 0001138476 2011-12-31 0001138476 2012-07-01 2012-09-30 0001138476 2011-07-01 2011-09-30 0001138476 2012-01-01 2012-09-30 0001138476 2011-01-01 2011-09-30 0001138476 2010-12-31 0001138476 2011-09-30 0001138476 2012-11-09 iso4217:USD iso4217:USD xbrli:shares xbrli:shares 407754 368459 1359467 523864 3998 3998 61511 0 503 29853 49127 53947 1882360 980121 106732 80963 80230 56471 26560 12537 25543 25543 239065 175514 123898 104294 115167 71220 8158 8158 2005685 1059499 32769 86482 240216 126770 363555 1611 6947 6592 25032 21903 5404 5404 4757 7803 678680 256565 1814 7069 680494 263634 0 0 0 0 802 802 623629 623629 700760 171434 1325191 795865 2005685 1059499 20000 20000 0.001 0.001 5000000 5000000 0 0 0 0 0.001 0.001 50000000 50000000 802424 802424 802424 802424 301077 205362 691574 565831 205238 171092 569584 455761 820486 487943 2255011 1006308 1326801 864397 3516169 2027900 7153 3903 19605 9691 143326 93946 354019 279173 440890 363206 1236088 791842 77558 49428 195833 146380 54854 40766 152761 107947 114550 57199 259972 120825 31285 19370 51969 36463 143285 107987 356349 301512 1012901 735805 2626596 1793833 313900 128592 889573 234067 0 0 0 -1564 170 224 551 760 250 0 1750 0 173 285 604 934 247 -61 1697 -1738 314147 128531 891270 232329 127574 53671 361944 85182 186573 74860 529326 147147 0.23 0.09 0.66 0.18 802424 802424 802424 802424 19604 9691 835603 274120 0 -5400 61511 108800 0 -35100 -29350 5760 -4820 -26203 -53713 30714 113446 91969 361944 84854 -3129 -18414 -3046 -4720 107746 57656 63551 50443 -63551 -50443 4900 4570 -4900 -4570 39295 2643 349552 352195 604 649 0 -38718 61511 107346 PACIFIC HEALTH CARE ORGANIZATION INC 10-Q --12-31 802424 false 0001138476 Yes No Smaller Reporting Company No 2012 Q3 2012-09-30 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 1 &#8211;&#160;BASIS OF FINANCIAL STATEMENT PRESENTATION</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The accompanying unaudited condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;).&#160;&#160;Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted in accordance with such rules and regulations.&#160;&#160;The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements.&#160;&#160;Although management believes the disclosures and information presented are adequate to make the information not misleading, it is suggested that these interim condensed financial statements be read in conjunction with the Company&#8217;s audited financial statements and notes thereto included in its Annual Report on Form 10-K for the year ended December 31, 2011.&#160;&#160;Operating results for the nine-months ended September 30, 2012 are not necessarily indicative of the results to be expected for the year ending December 31, 2012.</font> </div><br/> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 2 &#8211; SUBSEQUENT EVENTS</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In accordance with ASC 855-10 Company management reviewed all material events through the date of issuance and there are no material subsequent events to report.</font> </div><br/> EX-101.SCH 7 pfho-20120930.xsd 001 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Disclosure - NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION link:presentationLink link:definitionLink link:calculationLink 006 - Disclosure - NOTE 2 - SUBSEQUENT EVENTS link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION (Detail) link:presentationLink link:definitionLink link:calculationLink 000 - Disclosure - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 pfho-20120930_cal.xml EX-101.DEF 9 pfho-20120930_def.xml EX-101.LAB 10 pfho-20120930_lab.xml EX-101.PRE 11 pfho-20120930_pre.xml XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } EXCEL 13 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]A,#`X,F$P,U\S-6%C7S0R9F%?8C$U-E\R.#4W M,F%F-V0S-&,B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;F1E;G-E9%]#;VYS;VQI9&%T961?4W1A=&5M M93$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7 M;W)K#I7;W)K#I3='EL97-H965T($A2 M968],T0B5V]R:W-H965T3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]A,#`X,F$P,U\S-6%C7S0R9F%?8C$U-E\R M.#4W,F%F-V0S-&,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO83`P M.#)A,#-?,S5A8U\T,F9A7V(Q-39?,C@U-S)A9C=D,S1C+U=O'0O:'1M;#L@8VAA2!);F9O2!296=I M'0^,3`M43QS<&%N M/CPO'0^+2TQ,BTS,3QS<&%N/CPO'0^9F%L2!#96YT3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,#`P,3$S.#0W-CQS<&%N M/CPO'0^665S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^3F\\2!&:6QE M3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^4VUA M;&QE3QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'!E;G-E'1U2`F86UP.R!E<75I<&UE;G0\+W1D/@T*("`@("`@ M("`\=&0@8VQA"!P87EA M8FQE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-C,L-34U/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F5R;R!S:&%R97,@:7-S=65D(&%N9"!O=71S=&%N M9&EN9SPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$F%T:6]N/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW+#$U,SQS<&%N/CPO2!D:6QU=&5D(&5A7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'!E;G-E'!E;G-E"!P87EA M8FQE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-C$L.30T/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5S M('!A:60\+W1D/@T*("`@("`@("`\=&0@8VQA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%]A,#`X,F$P,U\S-6%C7S0R9F%?8C$U-E\R.#4W,F%F-V0S-&,-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO83`P.#)A,#-?,S5A8U\T,F9A M7V(Q-39?,C@U-S)A9C=D,S1C+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0@0FQO8VM=/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T>6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/@T*("`@#0H@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!4:6UE3X- M"B`@(`T*("`@("`@/&9O;G0@&-H86YG90T*("`@(`T*("`@("`@0V]M M;6ES28C.#(Q-SMS(&%U M9&ET960@9FEN86YC:6%L('-T871E;65N=',@86YD#0H@("`-"B`@("`@(&YO M=&5S('1H97)E=&\@:6YC;'5D960@:6X@:71S($%N;G5A;"!297!O'!E8W1E9"!F;W(@=&AE M#0H@(`T*("`@("`@>65A7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^3D]410T*("`@#0H@ M("`@("`R("8C.#(Q,3L@4U5"4T51545.5"!%5D5.5%,\+V9O;G0^#0H@#0H@ M("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/@T*("`@#0H@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\>&UL('AM;&YS.F\],T0B=7)N.G-C:&5M M87,M;6EC XML 14 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Balance Sheets (USD $)
Sep. 30, 2012
Dec. 31, 2011
Current Assets    
Cash $ 407,754 $ 368,459
Accounts receivable, net of allowance of $20,000 1,359,467 523,864
Income tax receivable 3,998 3,998
Prepaid income tax 61,511 0
Commission draw 503 29,853
Prepaid expenses 49,127 53,947
Total current assets 1,882,360 980,121
Property and equipment, net    
Computer equipment 106,732 80,963
Furniture & fixtures 80,230 56,471
Office equipment 26,560 12,537
Office equipment under capital lease 25,543 25,543
Total property & equipment 239,065 175,514
Less: accumulated depreciation and amortization (123,898) (104,294)
Net property & equipment 115,167 71,220
Other assets 8,158 8,158
Total assets 2,005,685 1,059,499
Current Liabilities    
Accounts payable 32,769 86,482
Accrued expenses 240,216 126,770
Income tax payable 363,555 1,611
Current obligation under capital lease 6,947 6,592
Deferred rent expense 25,032 21,903
Deferred tax liability 5,404 5,404
Unearned revenue 4,757 7,803
Total current liabilities 678,680 256,565
Long term liabilities    
Noncurrent obligation under capital lease 1,814 7,069
Total liabilities 680,494 263,634
Commitments and Contingencies 0 0
Shareholders’ Equity    
Preferred stock; 5,000,000 shares authorized at $0.001 par value; zero shares issued and outstanding 0 0
Common stock; 50,000,000 shares authorized at $0.001 par value; 802,424 shares issued and outstanding 802 802
Additional paid-in capital 623,629 623,629
Retained earnings (deficit) 700,760 171,434
Total stockholders' equity 1,325,191 795,865
Total liabilities and stockholders’ equity $ 2,005,685 $ 1,059,499
ZIP 15 0001185185-12-002526-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001185185-12-002526-xbrl.zip M4$L#!!0````(`&YV;D%E25-]2A8``*BH```1`!P`<&9H;RTR,#$R,#DS,"YX M;6Q55`D``T#VHU!`]J-0=7@+``$$)0X```0Y`0``[5WY;]M(LO[]`>]_X&:! MP2XPBG@?MF-`T9%H8LL>RTZ<62P6%-62F%"DPD.V_->_:E)'\Q#9/.3-/$P& MD]ADL[ZOJZNKJ[J;S8N_M5K,!V0C5_?1E)EL&+/[#W_Y3Z;%=)WE:FR8S-#V MX:[AFVL$U^PU8;K(6G9WKLW M!!"^_-9QYVV>986V:7N^;AOH353R#-\U2Y1?S19.K/A*-\R9:2R0;OD+0W<1 M/*K;YHONFXZ-*]7&)%E-8'*VYKJ_V96>Z-PG+;F]D2+=,^WM.]?'MB>X=U&7E%'Z\@M($%W^S M0EXFF?!.!AO34_+:(RJQ>V!K1?L'LJSJP#U9UREGE M@`#7?KR^&D-K+_76WC0NP?H8Y@(+.//">W=HQH0"SW!-W[WQS.7*PDH,KRU< M-'OW!EM2:V<;;Y^]Z9OV5I#A0/=Y]AES^NZ-P?ZGX]W,!':,5KCPF\NH?^"_ M+Y#MF_[FG/)0G4X0145^:)]>(R4WSX` M["ZMD&LZTSADJ`?_,FI.K26P%^W=M;VDPW-1'=O;2NXDQ2O-197F>L@`J=S/ M76FN!?46N-J5YO\S<)TE]UM@84W>.S]SFT-%7;\'SGG;Z@KTXXOVX2K#D*61 M/27*1A:RNU9160*I+.Z@K)_15F+*XDHHBVM(6>)66;K]Y[,L[K4M2R*5]2>S M+&IE-659\=Q\]:9;X5 MUKI*E0/;C.H;0#Q&U'&)="]PT>4V_#Q[&/?I[XG11WBUQO`?F! M]^9R+W9JKJ'.L7K@1T;!$B=7CGMYN$%#8B^DG902E]]#MK,T[=V]+(PP+SJ+ M"&?4]("2E+77]:%N&;H)T[M_?;G^+/S[7X_&*GC^:DO:]$59S[]N[(=>\/1! M<37E$__MX7[C6&&MWWPM6-]YO]T_7J-K]'2U^:A]_/1-'LJKR=KH/7^[ MZEQ]_VTUZ`3?KV7WXK:C]>Q@^#YZ$B?@N4:V$Q M?WQYF=FSE^_.]YK#\87F>67ZB/:]#NG%98_2CNQJ/9R]KM)Q/Q<^/7S=WR\_BDSKYHGW],K$F M2\'[^-XRC1?E5C?7F\?!IV??T3]^7J]L;\;WT?/[>TV:B)\YU]N,GD8WCY\V M_MVH\^[=OYGN^`XGMW%3VAM1PC2/M%BV74;YX%E7]Q8=>XK_Z?\(S+5N05_S M.GY7=]V-:<\_ZU:`&/SP'4Y9<*=@METFO)#*3I@I,LRE;D'^!(.!R"J*)%ZT M2\%=-DPQF4O$*0JR*DI:/8H=PW`"*'6'#`1/3"PT0GXW<%UXM+KR.$'21%DY M4,N#N4PU;552^>J2>$&517I.,4I#&[)Q=*\_(Z)\=04)FJ8>F&0*OZS+H,!X MRC.X==%*-Z=AJ>I5ESF)XP[(I-",7DZ+F5]9]AA>IME!'[KQ%\@]:,)KHE-( MK)`VOERLE!769IBO)EY3I2HDI3I3D4^`Y! M$TMSZ'@>\KWZSE15>4$F3#@F-\-[TL+F5UE3@0J7@YK0MP,!JK^YM2!H!8/! M`]!J"25#RZE1>596!)[4?!Y.VF-5996O&Y759(&>5(S3('`!%N(;*#@PG_%/ MW@?7\6JX5)7E!<(^CB(TP:2@G\BBPM$SP?/(9S>SF6F@O$EELQ#CR)<-L"D(,[F-'(FJ2P3 ML+8F_8LDLF*:3"9(RJ@K4RI(0AN@=(?6R`X:F+Q2)"6KK4CIZ8RH/(N"T$O- MMIA\%DV:B:RHLDJX?HJF:-(D>$F6R%20`OZ(TVDB_N143BST;F0DV!RQ`CMA M9:TZ,4*I-0Q%944RZR*$YEIH#=N0(2*@1>PZRZ7I+U$T+=X%%-.>(]NH56>B M7^3(3YI!-2;4"R7T3&[=K4,9^X[QO>:Z:WRI)BDW>[6A#'J9A2(*=*PEQVZB MXBK+QY5/BLUH>UK4HIEL>M3.%((+\`"Z=:N;TZ&]]0\U^CHOR#R9KV4#I!=6 MRA,I"#;(IJ9AEECD%!85B%7?8JQ,LRS'L&BB4Q. M)/UF)8*AL2T<:XI<#\\`^9LZNPYXB=.(Q"HM/.W0RQ$H&#XU226CC&S\8R,8 M>-DFM9&:[RF"2B;==:B5G"`J2ZUC6HG_.Q\(?P M"F50D[ZS*<8%L4QSC./CWZWNWKAC'W?F<&BX1>X8;]>*43UL$Z36L@!C[EN6 MY8Z-N\=P3T7 MH[N3D1MZ7E!;:P64(HRLEDZ,`S4\V7L_%U:9Z&@?'9C(L]"#5>5'ZMJ9X->+6(+L3>3&'T<&1-,"F M2$.-L6G.I1522KB.IGC55E4>K[%NX6V\X>3N&+EKTZ#8UW7\#<[$ZAG+L0HQ MI7T4+!FS5V)U_%7)9-PK00;_6JR.OY.87%SC)$5\+5;'7_Y+[M&35($KP2K< MW'9].QJ@_*E%6A."QN(%=;MI;BLWN4&/`H[6-CB%8_%J8DTXVD:79$U2Q=IP MM*TI2I(B4EBR47^(V3JL:$U$HYE98%-[C@J8K.]U4B?YP1>5LFP)DCEQ(JU=7VD;F65[16)8&EF;_8A.MKG!2;-VYO M/^LRI344(;&GXO69TEH7I\FL5)IJLUQI35*3R>GX*EH-'577\<(=HM'K-CPTE/;#V,UL-T_32`C$B9"K M9HR6!YAC$PKT9&CM1U(X+2NL2'"I0X4ZA9%/K!=JF^%9E9&H#3@U!-YFJ`D[;0V./6T'N1=2<.L#4[;^H(LRLEX]ACXUIO@ MO&JZ-&W3\W&@NVYRU(&D*68&!9!'1\0J'*F-!9RLFG:RK\*1/HF2!5'[[W"D M-CV6DSB^!L=]IM6D'^+@DD9.)Z904GVR#`U:(U,$224G8S)85"=!/4[)O"QI M\JET03U"*9H0"\_I:42G#UTUM4+)";%IT`R8K*&R'!EJ-P2.DGR5[21D:"U% M535)R6JA)LE03](((DN^H4Y'YH-NVAZ^A[P;.US`N)D5OZ],:SJ$U1P'RG## ME4C1FM"KDJ(UI5XL.24AZMA:XEZ'$/74GURAR?`+N#B+QV5&CNTTN4S!2[%U MO6R@)@A5<$HY=-++G>4944_T*)0ZJD^)UHRJ*6EG7TTF;.2HGY"?=M(E"%"[ M'#)=;)(`]58L5CP-`>JE4*$,`=)$(J-IT!IX!-8:)WN@-X)EMY.W8WGLT;GNO>Z8!WJAG6H%/O@.5\X(= ME5'P^%4[GC")`N3+YGE264_(D]7^FSRI#"WD26X^>7V>5!89\N34JCR_('.^ M@,N=-8RENAZ)_AW;ZG)%&4C1! MDMG89&8Q;O-LZ3>BBQS/-L]V=X(CD3\UO*A'A9G.O>KQI)[_DD2V/%<*O=)^ M;8AZUCG^K:-\P$)MTK*CWX>JJOEZ3'R_TX9!G7 MU.0J`B_S^4-IDB;E&+H]RKP134J"PE$-]UM0BO8N09-^DZ3"B>58%I-,'(W? M2/#)"2+Y1B$-+F7T5((M=3@:WW)-2Y:.*^&!&[37C/E/6OA34:>>)XV_2E2. M.649[A00FO2XI M2%+K4E3R!]4"DOB3E;JWN'4=_&WGZ?O-@X>->;_MM&/XYKHY3\LJBAB?\J9$ MOSP%[1+AE521=?KE2WT3KM#=.QWC1V"ZJ-(WNJA3+2&VBY`>_&3,J77.BN2I M-;68'VFP:+VT<2-O)91.CTYGY"5ITT\?Q#5>F?8=A,=18]W,KAQ[?H_"WF MV9^4OT6NB3=AQ$?@1N)GC=>(G:)EX#-.=FV(//5LKQS__FDY[A34.]"2KKN! M1BO\ZH,<.V"23:I9U"2)+^*:@$M]AJ8F125V-F9COW-U_Y'I=N[ZS,W=A\YH^$?G?G@S8H:C[D7[&`Q)H^<8 M`0X,[CGB.;?T>B2D^/4BKQ?$MO*,V M3]IE4J$UC@=60]>HC9QU[IH^'19!K`,*FF(E#2Q]3EW]&2"C""TF(&U#7;@3 MGF0R1<^?T(8:@67!@`555.18I>+2+IDT7M06$%/BM6E[CL\F#SQJV*_(B^%E M2B.BHD/1SXX5V+[N;@:FA5QZQ)%#`B:D9"*%M[I@7W/'I5?H&*P%GF/V=6'` M0E:ZO2'A8Z(O,["_(,OZ9#M/]AB"%,>&L!$?T.U6K.T1:9=I#W#H6P.X0J]= M_'?<&20D'<6*PK)R:+\+65B$I)C![DI%]\MZ(/QWB]5:`AO'C$E+'QCDSG5[ MNV6C"PF58YG3W7:.6W`2^)TT_.O-;)L-Z%9XNG^8GO6@.I;C!2ZZ!X;O+7`M MU'1_L?SSJ;EF/']CH7>__`@<__R^_WC?&HYZ_=']&<.N_'.F-QS?7G6^GC$3 M+/R[.%+/R(V<:SI`7]T<]]/O^^, MAV/F9L`,AJ/.J#OL7#'C^\Y]_QJ4E!1Q>]%TS_&G;-^"7V:XK MQ/3*`-E=SV`6^AHQ$X1L9H572%UX:K)A_`7:>5EF%;A>`#$.XSOX>D*4&^#5 M2/A]QO#<.>8?.^/B MV?-QO[O_C3O_Y]N#L1U^ZB(7?ZHMJ2?3GCGN,MI-AJ%GCN/;#GBIZ=X5>(R- MBUC6!DH;5C"%JA\$[27M=4AJ;:\KTPZ;Q)WBP\Z8)]-?,//H5!EKLQ=%MAY: MX8;1HS54W(@K%]#-%=;BH2T.[>FXC+,T?7@H7<44M!<8B^P6R=3=WKZRM#8+ M7-OT%E$=<6.:.%4SEP2WI'EEV==6M3ME`R?\P55<<7V*>U=4*F([LY#A>RF3 MMRRR[*_,T\(T%K_N:#DKT\9\P>2@-^GS$/=7!EHGU90V,I#G08P"YN`R.C/3 M31*"%?KC4OV?(BEKI\#P8/`/]RD(ZCIU!8SYC>E#!^1PR;I#J+W0? M/^1ER,II;;)Y)PC:30]M!$I^"VP#(R>U%AHGX5/V`XAR#K7>^K!,^:"2I##< MC4-EN@@T071=J)_'=&P[`!%1L,B`$@:@#O"KK4^XT1/."U/:0$#%0"8`(GI@ M'WBK+2-POS(X#\ULX_V*4J9NB=IJ81'DRU\ZL[(*@_-`!Z7D&_P1J,!X,H!CQ@_OQ_W?'T`3 M3/\S_#W.L(B_XK$0;&@GNE9R_.V,NXPJ22V.W4=/Q$#@HK6)GK`WMZRTPP6? M#0X77!<*[1PZLAN.)+B_XV@.]WV(D8(0#8\4H0?N-MO#/\?4$L#!!0````(`&YV;D%81%TD;@H``%A] M```5`!P`<&9H;RTR,#$R,#DS,%]C86PN>&UL550)``-`]J-00/:C4'5X"P`! M!"4.```$.0$``.U=77/B.!9]WZK]#][,R^X##81T"*EDJ@CY["8)!2%)[]34 ME#$R*#&2(]E\_?J5C"'86,:`A"$[_=*)8WRNSI&N[M65S-F_,AGM!B!`=`>T MM=9(@Y5_.[W_:!FM@GMVPX#:'7+87PT']@&[AOJ`L-_9W[N.8Y]FLX/!X)O! M;J4&)(!BEQB`\@M:)O.[QO_]\Q]G'*1"`(=.<\=: M\ZFB'>;RAY,/L4]8$+VW=`JT8<]"]/Q@#FS8(M8W3#K9PURND)W>>#"Y\W3( M+P3N'Q2\N_.E4BGK_75V*X51-[+'YK.O]]6&T04]/0,1=71D<``*3ZEWL8H- MW8$8);!+$][!?\M,;\OP2YG\8::0_S:D[8/?)\QIVAG!%J@#4_-,/W5&-C@_ MH+!G6]PB[UJ7`//\P#:[.,,YS)4*.?Z,W_B5OYAB%%NPS;F_T"W>DD87`.=` MXP]NUN\";;!U`YJ0M5&WG*ZA$\"LU1$<>ZWEJF;YI[+"AV:5V'V'&#)H..SG M'D#R3`\_-SOML'+-K^BT>VWA@32[9P]D!GO&&KIEN);WB2HS+6`T&#H`M4%[ M:C9_FE3-/TECEEC8"*!;?*1@,@6W]!:PS@]=1??;BPKUOL MB;3L5'1"1A!UGG7+!2J:D`S8:YK?L+G>4";!-NK$F-K(?ESH"D$'Y=^1I6ZO MYSTM`]E`F7[>)+BW1$D'K\P?)FU`S@_R!]H`P$[7X3_ZO7SUWF48V&4@=6`` M!MBRP`-P5':V.+Q@W]M)B>+Y\I4Y#"FSGC03S_ND#\$]1."B%@ MQU>@$%9@79=6(\#68=O#4<%]X/D[[Z"";/A<'\GT0\S]/3I=0#XUI=MQ2/'` M.Z],0OY\R;[+D,SO#%=#&R`*%$H4#;3C_DG`CB_`L3S_A&V6;(YJ+-ATF/@\ M;K!YH'Y#,%7DL6(1/[,;>6WQ>O16VS)!#+0EC5Z63-U@MXOG4&;L>.T2!!V7 M`(9S#8?\)ZJLVXG!]E"E&.8$(>1*`GG9]:/)$E8PLR511A[^S!Y1&]UF83BX M9GYK0T>WJD"GH#V9`93U=R'67#ZQVXHL9TT00,J?0!Z`HL`D!B_]9#8)'8GF MCJ!Y@X_BJ;T#I%68$MFZ+L4+Q MQ9Y*^1*&,U*A303*AGM7)@[#>ZZRS7=1,"G/<6*Y0B7Z17Z$@WR](8Y[/8S4 M\K^`D:YC3<;](C&RAVRYS4)*9JINU738OD.^UU"RFB"`2M^3)A-#2)4HC5U+ MD#IP=(A`^THG"*(.#90:3&A`)?-=`M2]<%9)V!/FLYN&@F74WLX,N!1SAR+U M6%($L62"(NJ^M"KJKIC-*V?9T`&,E(YEA,^SK#T\_"Q,29HT>_9&,:MN\;W1 MWI,:@/2AH7![EA@L]F[:GBZ(M MV!AAQ+9^[79>#T6;=B)Q=KJ31C,C/NG@'R;]X^7^N?#G'Z^&[0Y_H>^E]KC8 M[_P:H>:E.[@IDE+QY^%;\VE$K6+?&.>L'T[)[=?ICZ?7>W`/!M71;>GVY]OQ MW;'=ZAN7P[=JN?K^P[XNN^_WQZ3YU>F.\'.<.>R>O M8'0U:L*'MTM<,IK%RC4V]=KM)7@D.>/AHV(W&N:X#WJ=]M'SZZ]1O?=\-#AI MO91^O;2L5J]`;R\L:(R++';MCUZO?PX=K-\^]VU$S<,K,+Q[O**%2OU('U0^ M/F#W#=ZZI%D^/_]3JS3J_"CM>KW5YJ>!62#F;_!6XE0703998UV^FT?-BFL" MW'0S5J&6P<77)/Q)WB+GC?P*IM[.F8EQ,V.5^4817OK9;"*AXCF3L;UZ%C7K M+4P82AUX:9@/IB0MBD9*.T1(I(>()?DG];`)*/66,1:#+6D;?H,8>^"X%GF1 M7/:>O!G#ND/4)?S$N\)Q((+:$]D3E[/4%4!H6!@#VI.^'6)%9L_:'%0_&VCV(('6X.?TM."(AY![,"TM9\R4Z MD17+3HV:K,!5%2U$1<'LBE]:;'EPA7^Z!+"L!KG#C8CH>L*#(.OUHP>,<-`6 MA>-<#+9)P*1#1#F!@#XB;UWGT51WOB4&+5TOM53(@+>*X4PT7-9\ZTH?4(>7 M!B8V>6]V8U=42"/$2MEAK:2,F##9%7V^4Y1'SQQEWD0U%1@!UCY)(R9,=O(] M%5VA*PY#I+YDO^(H"1&TF(1OX@P@W/0:YDCMJF^6D'4BE(%1F@S<=Q2V;0_T.: M8@:WW++G`W#4)D1!@/17"R(;O/AFMRTI+_,$X\P@OZMV77["3\;6SL$36"^Y"9=C%J4KXI:>:6R_PETLK.7ZR`_K=+ M6Z7/KZAI8*H)TB73(\T7K;=^Q1K%$RLYS66\@_&S+)9C\?X="Y^\5 MS2A+0/=]G"6@59`6RU,Q=&9_:T*&<5->^9.OXP*QDHO<0M"Y*'3;HU,`_R7' MJ8AJF97S1>#0B=OM*!L&_7IZ+M`JJ+__75U)2[,$Y9;B8IXF/=Y1_M[[Y;C[ MK&(R8A?K_-+UG`[X.0^^75\Z#[S?F4A"BZQ.I8Q8 ML);L9I56U9=@?K79,DSI5,6"M$*\8'JN='72V7;<,P7]NCGDC-:ID(L[*J06 M:B;5P[0*-5'HZS>QIH^\,N@3+AL?+B1@J^]87P%]1YU03%\(G,!9@>;%ZL\& M<;O`[&N(=&2DU86CT-?OPG7FS2?L/II5C#I/@/0$[P=3LTTP.?S.^N"8_A#< M3;@"U:)^O.Z;\J*^&+,&".3;.8)3@PJ95\)/.?!=AZM0.3KQ1+V#^\84-3_2 MU2_YNL\OU/Q(%Q'W=K#([3IGLV_\]N[Z'U!+`P04````"`!N=FY!^G3/,@42 M``!)#P$`%0`<`'!F:&\M,C`Q,C`Y,S!?9&5F+GAM;%54"0`#0/:C4$#VHU!U M>`L``00E#@``!#D!``#M75ESVS@2?M^J_0\:[\ON@T8^DCA.)5,E2U;BB0^5 M9>>8J:T41$(2$HI00%*6_.L7X"&+$L%+:)',,B^Q91%?XVN@T6B@FV]_:S8; M[[&)&;*QWA@N&Z3S;WOZGT:ST:'3V4`CC4O3YG_5;#+'_#-SCAG_G?]]8MNS M-ZW6X^/C[QK_JJ41ABWJ,`U;XH-&L_E'0_S[YS_>"I`.PP+B3>,SQ[FA\\;1 MB\;1V9NCPS>'KQH/]YW&\>'1L?<0?\(@YH\ALG!C,35,Z]W!&MABR(S?*1NW MC@\/3UK!%P^\;[Y9B`]"WW\\<;]]='9VUG+_NOJJ1:*^R)L]:GVYOAIH$SQ% M36):-C(U`6"1-Y;[X175D$VHF4*NAO0;XK=F\+6F^*AY=-P\.?I]8>DK$?EW M='L%L][`RY;WQP.7L$;C+:,&OL.CAMO'-_9RAM\=6&0Z,X3H[F<3AD?O#F:C M"6T*L@_/3@X%V+_$)]^X:BUJ$%THZ1P9HLN#"<;V04,T_'!W&>KL#&ED1#@9 MR+`G&F*82X5,\N32(M3?$D^UI(VV_O"&!IS8)MHR+!`NK&)`=.K M2Y,+@@L2S5'C-FVJ5^8-K&7E^:(LJD+N9.4L0VW M`E.+F)96=HGY#ZRWL/LOW2[IA.-:'*:IXQ%R##[/?9CUKJS:(*;=XH^T_.^T MMA\/6`86EDX1,7/+ZCV]-G<@I)WP)ICF#'%SA9Q-X*@&UJTE",4N-'B4!=@&&F+CW8%C-<<(S;ZMUDPN-+[D/UJ1[+DT/QW\5/A\R1P=&M MMMU!C"V).?Z$#`?$MTH'O'*L]ZFNY&&W/@U2,IABD<]GF#2-.ASP#FN8@W// MXP;;OO`@9BH.+SS)2ZJP>,;26+%0(304#52@V4LS1-<5)&$* MR`/K,SQ#1'?A(-01:K\0>Y97#V%F4DR,G0P8MZ&W]@2S9^FL_5BR>.!*:2PE MERF\B5VFTL5BQEU^#*BZ:*`*F3@)4[YB3A2;.&]-A)Q*(8""O(#BG,8[B7.Q"Z`BY5I/Y/41KEW-HD,)`_^W&;)0^X;R#L( M"^!=&PECGV(1(0-B"5YRRG$8ME7Q]"7Z9;F4UG,89\5AF"/VR$+\9+UGU`+Q MT>1@U5)5#&F)[EMVFW8[&A$-KV1+9<,VGZD&O]'=A7*C.FA&;&1<8<1;\U8G ML)$OQ2HB_IAWV,L)2[.F*%Y4P%25@%B-F926OD0O+.]>TYDZAC@Y[^(9PQIQ MS];YSP9VR3+U]I0RVS]SEPH)M!U5(UNA.]:41P?*])#"6U<[O6\PT(XV!J_@ M#54ZG<8SYNOII7+GWG5"/9M_0TT-;H\;#53:/5<"/[X^7H%$&N!"#.7G.V#` M)_A4,<%7!`V)P;N-19!O8%/MQX0:',H2\XTOP8`GU*FQBW%%LNDI/9&^)E\K MW#GYP:9U&7(<;$<]7MKYD=AOG^8SY2M$$`_LHZ4(!N[A1&$#J?!#[)AQ%G5Z ML$D4X-$U;T!?DPY6-Q*P`C=.F?4CXTMM="<`=$_^X*=-%$QAX8=L*HED*,UE MG=TC0[=#@XS=[1'DM$E`K,S<26(N,5"42U]=/,(<0+_C&!W^/X$\SY:#549+ M,7S!!(0"0#Z/][,,Q0-6Q.HEL)9FK[_K?)ICTX%NP14UQ_>83?-N+^.>+W%P.;GO@9>L^*A:XEO`AB.3 M08N<&BF&8`KO+")@&9LDM;/M`C9:141G\J@CQ`C4O<\.G4Z)/<7>=<4.-6UB MCK&I`:DA#J[$1BT56X&*U%U:=T?-8((83A%=EBPC,8^7.TH9U^^`:H#-?9_Y M3IL;C`9+O(F"*6S?D3S$-F[-;C,$MS"(.4=-6&UL810X-6(&X*8I"M,"%B#6 M=;?_R.@CHE^:OIL`$AZ60!5\])Y2)5*BX!)B[T3I&Q/K%XB9?"FR0EU1UJ7.T!XYQG82*>3=I$P"5.%V949*8:XOA9U^[E#=,E=Z MW?7_^YBY'B=\C$V*7)%[_>E8!"M1%!;`1;/:CCVAC#P].^!PZMM"K,($3"(- MYKY3%.JE93G[4Y./5MH#AC1,)>N7BK[$NU"[:FX?2U4<7$6.M:5LI;@=I49%<$N4#*H2GI^4 MI\2,*&6:`5Z?8O&JJ:.HU2DQIZH\,?#-=[CL'+"LH]YUU+N.>M=1[SKJ74>] MZZAWZ`*/FQH"6M-^"Z/T&_YM5I(UD&^:($.4-W;1!IC-B098WTX.5NQN7C8& M0]-#3I3R9<:]AW+=O^GAS4OHDCO.P7<+W6K'L1CN$=1=?K?(S+JB@*HD1>*4 M?PA'TP-V8!*(!&G1B]X=QXVX*'NNNDRI.Z_\\LW9LNNV'BKMFBCI(]BX35,* M#F),I\(M*G5+-L;"V;YIB`/R]]V9V*&66_/-$_9V)EZ_#12SB\4K,N^P>\G<1X;0C@2IN%O%:;0BHP?N/0ETA"W+3=C8=C65%90, M8Y39@&T3`O0FA/?8Y+/-N#0MAXGK28`S0095=A,EI4CYBQ&VC.+M*-C@@2X< M:S"%)3YF6BS6>8$KKN+"!7*!*6`%4/9YL$%'BLHI.YDDX:[I4\Z!D,@F\SV8 M)BFDNU2\_:W9;/S]^?K3R7___J+-G,57\^69_G0Z'W]=F@]=Y_']*3L[_7C\ M_>%^:1FG<^WIT/C3/G/F=]:?]U^N\35^O%I^./OP\?NKRU>SX5SK+KY?M:]^ M_#GKM9T?UZ_8P^^WSJ\/CZ>LO>'FQ?"`W MW[OT3'LX[?3H"/4_=/$M.]1N?G9F@\'H:8ZG8_W%IR]?EW?33R\>7P\_GWW] M/#2&TQ/KP[E!M*?3/B+SY9?>QX5-T8=/\YEIC8XO\.*\A]GPK^'5Y/@,S#9-,*]3 M60%Y!^Q70('F*)@B$W)3ULB.(D=]WJ?W%A&QK'@XOLXS18]B'B]W'"FNWV"> MY7LNN"74B:U;TXT6WH[@2I3'H!6U^4H>;:'%(H8NH.C1I3G'EEO7QI/RTK0Q MXY]`Z$>*5=@N()MZY%Q!GA*;MM@,"KP;:E+(R)X4JR+ZD7,%5Q$X&`.`NX5- MB`*KR6:=+QO((J(/3LS_6XM%[5-(?# M^PX?-:US/*(,K[UQ^IJ8E!%[&72(>_/A5KSR$M?8GE#]V2*#.!3[%+\"R0)[ MU6:*.-L.0Y(+YP_^<[YI',$42Y)!5>)BNY0GL$#<#;9A-\=A@$IH88,3F'K% MY\@BFGACJ6,8RRXQ'/NY-%:0KI5IDYRIP?*&)W*0DYR9DVMJ;`(&0OGR0$R6 M),BB=M1Y!NOZC$JD$JZ>Y6=,QA..T9[S]7*,;QS1Q=N1*\9:VM`>E)M3DL+V M@;LJ/2_SE2MAUD'6I&?0QP,565!;1K%.W:I3M[+JHT[=JE.WZM2M.G7K5TC= M\MXZXR^Q;OAB=7+9UFPRS_$FT;2-E;GJ1T9:H))@_C_B![G&8')(05GHUY6O MK7]W_$C>/;W#W.70B(%7R/>4_RCZD&FN9&ZTU!&>G#S!E"5?3V#8<\)'1)Y' M09,J[Z"598+D2`#):_K^[^]9J-!=BML7BE_PTYD@A@_> MU;EV;+D?G48!%[?\*5=K)*]P-Z6V!>@S/$-$WZ-&0X@%WM-1KLLPE5!Y>=NX M:V-GWQ8W&KJP(Q#E*I50"Y3XMXWOWB5[1M[3#-U"_744NDTH4"%CJ7D`O029 M@/D++9R;;,*E',I]L3Y:[M^Y#4`+#:U!>;0J:D%.:(,':%ZF0>*CO'C&JO6,7XL+2F2AO,59T)+_QRGK?UT",-\ MC/!182_[!C+=NEW\T]D4Z%5P&=`+W'%F'+NA4D\9Z`6ZYB29^Q$=V:-9C4*O MIH:ST*NXN/*V[#UB(E-39%GC&JN698VE!2KU[0[/_,E_.[JBYO@>LVD'S8B- MC"NQ<-\.#3+V$OD@)EX6^-):!%B5:FWS MX<;8DH\L]P5Z^]/G)G`%4M13,@CU9KN!,YMY>37("$S,I3FB;.K="`1\U4=: MZ/+/QM0DIGD-7D[_M8^(?H='CLC/ZU&6V665/5_B*93<]S1OL]NMBHZ`A@F0 MKK5?K->1,+*BZN=XK(#=B...C(:Q[F\U_3,/3T2HRMARO*(=_PSJB><-]*+; M\[D4U'P)0Q1YE2WKG-D@)_FN6O$9W#?4Q@<[9';6"=MUPG:=L%TG;-<)VW7" M=IVP':&GV[5E][ECU^T$Z;G)P:K@@L5051%?JHMM1(S:H:H=JMJAJAVJVJ&J':K:H4IPJ(I= MM+M4WW M,9USQ1%/6O[#II#25LM[ZT=.A&*+(X""@7?/O[<[TZ'6"DAQ3D]PN-_*BYD) MB([#&$?H$4M#QE>,V(6I=[EVNMNKTJTQ*+47J=I.%);3&Y9]2^,S2(UC,HBKD"FDT9ZTV6V@1%,*#\M:," MI\VET(4D/0,I&/+AYDI\?3.B[^KKQH1`NMC2&)G%%XG-S/-ZJ^7V6J*)2,X. MR&O:.1(3K[?4\>(C7BJSYAO-ECED&4.&ZAO]:U#>(GZ'9Z*6KSD6(CHQ6XN, M]$>W7G)#$\^,^GOYSYB?J.&8-F++'C$P4Z:&S6:K,0NVR$AQ0S\G[RY"AXLU MIDR9[0DW6A'7<8,)U;5'GH$^8\/X:-)'5Q4V/_//>^@>_T2!W9C];4L@#9&%70;^!U!+`P04```` M"`!N=FY!CV"H%M@@``#WEP$`%0`<`'!F:&\M,C`Q,C`Y,S!?;&%B+GAM;%54 M"0`#0/:C4$#VHU!U>`L``00E#@``!#D!``#M/6MSVSB2W[=J_P,V>S655-FQ M[,PDL>=1I?B1:,5J,G/`R`OQ7V>A M#U^#VYA@<#/8/XDEXANMXWZ96`,'C MTO6"7Y_ED#U.D?O21XN]@\'@U5XZ\%D\\NB1_*(P_N$5';U_>'BX1_^:#0T< MUD`,=G_O\\7Y9'8'E]:NXP6AY7!!-I]@.218]E\3+']/?GUN3:'[#)"1M]62U@XN8,P#(;3("3R7-P^,GF7B.#@\-6`;DY=<'0K M4H()1062TV^CSC[@[RR`"7/:K/3?[M2E0H_G>PO,$V_W=O+LMPP`R$,`"0@0 MP_AEC^+\K;"R(2KRPT*SE$+\8\72DA%[,Q]C686[;GZ!<^0O&W,R])MMS5ZJ MJ#KDG=L-VP9-^0:^I&#^E;$0_`B&0?H;JC]V!_N)$O\[!\/>;[KT!)L`CCH83B:G-Y."^+!9AA4;IPC"19R4^D@B?=O,N((;G/253`,KF M[``/AL"?`\MU_0?JF^-__,_!8& M80ZZ"@%C(^K:L1!)%9,"CCC%8T%H/>8$RJS[*.147EKXZVQA],8(KBS'IE!5 MB$I[$8DI>"TJK:6B)L[Z[".X@V,A7H,4EBQ'IE M18HF;KYON72"P/$]8"/KP7`P6H>K+%M4O0--!2Z1W-/'%4D_*10P-B*=)HE) M084.@O%@0[&N%),8>HBQQ!;6*([H5.J>`@(5_F_HAY9;G304R\0-`0)F28AN M;>5`#&:Y1`JDM*[ZWBN-[L?(7T$4KK$F(D'8:HGA8154*]U5!4-OXJN"&JYB MB&E^-BT3.H7'?^J*Z63)U% MR'/""$$,]\QY)#\%[Y$?*(E=^<@T2Q*7$(X09>/!#]9R]3.8)W-,I?:EN9<7 M(_&B:TL057E7\[DS@YE`2KD2VW,4\-[V9Q&!38N?).CFL)WN#K"6)(XC*5&? MSMIH$NQ(DE_CKQ"00__TYP#CA?3O^!=SQ[.\F8.]SY4?.(2>EP9-&H=?F0EC M[8N..(^'G.4W7&UQP>CY6H,-'337UL?6RB'1$+0":,?Q@3)ES<75>5F(^-B, M307GB]V6#1!Y-K;]LQ@*<`D8XQG)*BX6#]`$Z]\*M[MQ)I4)5`5&!6:@,G4@ M)DF82UBET4OL$3"U4;_\2ZZ,2>Q"8XTUG&%+'+FD).X$KA#$EI#80/RS"\D/ M&-UPZ:/0>:*_YY*B*&_>#6T=QMJLVF6U.\N1\G,8!$?`VB`!=@X+C=FM''C3 MQ\2="ME6&K^[;6Z>Z>=`O82*$OX"?$:2O"**.!*,_U*MI7NEH7/[.%@*B'H)URKO&4CC M5A$35-U!D"6.YS>-AN]&YZ.;T>D$#"]/P.3FZOCW#U?G)Z?7DQ^LE1_\#$[_ M>3NZ^<.H":K+_;S\U=H@K$B-\/\K0L!&[8O`_!6JO_^!8<2T26,W)2>W<1HSX%69\AI5=K8 M6I-2-`U5B5N8S)0A%HFH*HU?Q:-->X!"5K%*#1FK;%',BB)HYT10K:APD&D^ M%^82PI<8,KY<:FA(7L0LVQ(9P4H;IWMI%;5ZW<)"H]739!!0?4&BI%9,2(F` M0WGYX"VPS9%3_BSK:NHZ"YHQ5:E8*C!JUBYB:BK<2#^;4'&F:?I$D\]9WKDF M9R\:*Z$3.(<8C'V-(1WC_SHJ+U_PD6F6+BXA',%*QP,J7HD%,VK`*OF6%R#Q MGP?,4*M1DU(2I44$0/G)K/6O1`C(0M9HL1?=QNKMQ'4>^A%*KTB M#B:]$1>;"([TW'K00A[5072T83,F9A5;^Y16V33BTJ-NN#&6YF,8:053O+GC MLI)IIA.O`CD1Z9/ZN=1SWUO<0+1LFDP5S=?=%4Y`"^]D!<\`&.B2(P4&E4+UMKBOV,@A%_H(O?0-*IR"ME4^%CK>`WDR1'(C0:6ZGQ:=$U%4BGD&K5PMSS';7JF9B09=4++U1(\3)G86@ M1`$0Q[,43-=[3,\GA",6^0D__/WMP?Z;GT$\T>AI<34_,H^F8LD:S^O%E+"< M2O[NLSS+/R\76M[[3K(-M$1'6==$%AJM^4<&`?P6+TG:,2!#?P8_D59UY'\@ M('S`&CX*[WSD/.$A5@C^9_!R,-@'*PN!>P+V9_`$D9^.=8*`'.(2H^!'(>FB M;V.-:MK/%'!]JVT,<]-:'=1A"^-[:J6MA$-G+?@V!@ MY\>#'V7ES)3OP6+UML-1VJTV-4BV32]"6^[8#]JF%//SQ!(7K67-GYBA) MLTA@U6HIJ^GA2%8Z$&`V!Y-F:%S');6AC"LM5T2KDBX'%R*E, MF0YAQB7(#4_JXZ'1T*F::WGQX:RVDRP<6J.C5/!P4Z-C!V3)MDT'G65 M"D*6A(AE*3.=YQ/RN\ZEBW95NVD#[S,?G?C1-)Q';KDGMLI*WEH$Z*[NK4,< MSS7+6J3/?03L!`JY)Q^7CC_'OMJ)[[H6"EZ8UH*-I*'@PM7>L,9U5\4P=FRA M*S0A;91L&G&,(:+Y%?5I#RYFW1&#'%ER^9&=35":%U"P@BB.35^8#4+K,9^? M_1#N4G.S7D1"(0;#+/17+Y,EC-K[+HJHD17!"4Y-I9H]4&WL=A9)5BY?>CL$"&&?+7)0NJ2 MK3Q*TP*6HZ6FE.72MST7-0:+J^1M>UM:EB%AOE4_2?N7!U?P*^Q)Q;?*M9T6V@_]TW51M#>?;4LKL0-2<_^:[BO5/&%HTRT_N M9G*NR'55&+*%0UNU,X\";N%'/.S(N,O.8TNQL(.Q*,T1.XL&U@>?[:SQNW!M M=WC0KE+&0:W+REQ?,IT;/>)D\IW@A+48J5*&@;[I"\\MO,/3GA'&4PK-\%T M#0+HSG<=+XA(&ADN5ZZ_QCJ=EK;,+(0<\@\62)X9`>2PI-2`/"T4! M?6/(\@"F"UCVTO&<`%L(2!%=0!L^[I"GE]V(1C\KA/_T/7(";%3!$MK.C#0W MQGA=N,`_^?<8MK.X"W<`5@$.J:#;H7]>0`_;9!<$T6KEH_"E26=D2TXROR+/ M&*TWIW.(6=:`,,;@]RV[9\VO.=,VXWF-H.@)`B8>S-;"6CO;*IUL,S6Q*79AT6+2O\;P6]/;3&`Y?&VR1\G;U/6:CI0FZ;T0NHV> MP\9TV)'!-A:\[G#/4*DV=PL7.8Y'ZT$#YJWH_]@#X6%$MVDF936#&Z&]4&;\/BR]6DM[,_[.($T(HDLU&03P\DA1&*,&03RPJ$., M^B-E)C'=D*TUMCE3HC#3V$R99&0(C+BJ*79>$&2%%EA:CA="KZ@Q#'JGVRPI MR4%A4@T'AHM3I288R+(]P M$]K$RFFHI%3-E)`8N)5?(D*8T>[%DT9X&8A@NMZ3 M$3XAPE>QG5@2GB<*XL61N;+5:DYD"?Z*Q6H\1!%3PCI.X>Q[3\I%.V-"J_.6 M]]A##LBW#8,KCYYL7\W5/5XNP*;5/^22P7U"(:#%1K83K/R`U`#-2Z^=&W$+ M*[E7\`C%RVXA12/O'@:TM7(LI2./5%<%2@I(,(K--:MW<.XC&(^CK_Q>.)Z/G'"=2O30LXM0XL:$%S"\\^V-%57B6.LD MWT`*3N/RQ'F<*45#'NTTG.$S(*]%+:Z7(4VSDAG^1$F\@QZ"0H&@0='F\JPLANRU-C\]NX2AVB1V$8&1ZOP"";RGY2`C7OWK M7W[YV^XN^/+IXN.K?WWY/%M%CW]X/QW:3V_N%W^LO=N3Z.']&W3XYO>#K[?+^`%?#A??SC\\/O7UZ/7J^G][.3QZ_GP_-L_ M5F?#Z-O%:W3[Z4/XVG?>?3N!/QVCT_.5];_H[>'WI\GMV>/HS8]?HS<7K^X6 MGY^>YM[\Z9O_[>G]TWOX]!4^OIU_/QG?O?HIFBT^G[^??7H].%B^_0S7I^M; MY_+KB7\XNWUS?.;/K?&'$WB%!K/+[\>KR63^=`^7"_O'CY__6%\O/_[X\';Z MZ?"/3U-WNGP5?'CG.K.G-V/+N5]_/OO],?2M#Q_O5UXP/SB%C_X*3<.O!\/@ MUK\=#0_LG\9OK\\??OWU7^!X2\Q9+9F!;G%Y\@N<\-[>$]#E\6\#):3B&Z MFE-4N0Y2&J2Q(25:T]C-:.0(;PH,6#$T,$N:D_6Y8VP[>#.DOLE",W\RQIP")MG%K)QM.`N=^_@=H5I*31:8_F:,DI3Q%!:1 MPSF5PWR5(K:W5@;";#1:EX\;T:NS,_JZ)]:@BJE=9!C6B\!3"^,&>IW?4NZ, MQ2)FYO1/D@ML5$Y(N3:TOT;)H2Q%4)>G MG,8O_R4,'K0XM,OW!]'<+X;1)D:C01)0(M,?AJ2QF=UA3#>'J=D3AM,*1G?I MGKC&FJ4BBK7E].EO5GGYG[Z^O$T@=XRS8<-:I/FLW44+-C=+G/M2DC!GEU>%A3[)&^GC9 MQE/`#@B"5@!/8/S?D5=^FU=1@5@U7@,F2X8NCJ)YGLY]0>0T>\P99?-,UTA* M,WJKJDQN0UK=F-K&<9*\*)@KF=0CA2S$';JP;02101K7IXWG$#FTT\$(6UEN/_1,[ M%F_%\E;:AC97++9@YV18M^EEH^[.0VPC>4S:)/3>1O!8%K@W,BCDNE@8^3O3 M[E[A-AYZX7Z#09,:+&'MASANDU4EB<^=O%8DY3P.[9$(;&0]]$\<>;P62R)S M4[H5PD3S*KWM6H&S)VY@D2H)39B:XE(SII[(')NU4H:XBYZS_`!G;*WUA[\I M4@,WI<04\=R^=`)1]MX M=19ZRQ#$O[&7%SDRB:'G>B1T'/Y6RAUK.SK-N"0XTVS/\9V%%KH3@BG23L6QBW1@0IB$+&:I0`2] M,%63O1-'#I?E$H'YS5`A>LD#6'I%+T5J7A-N423C$H+((U MR@ES[Y&#(-9'6`.% MZS'><_JV&/[MB@Q182S)6GC_$T8()B50,)UL M-M=67P0*KTC5VZ*F25^.M61\&!H=+A;V_CA<#.JJ'*XHB)VM"@O8)V]+(`$2 MWA9OC]I[6V<.>;BG(V]+!,RLMR6@3-+;FJ<0^NAM27"1;;&K]L6,MU5!E8RW MQ6)7/[TM5;QKX6U=PU5B+J_FY[ZWN(%H>6RM'*+@29KB:NHZB[@#I0HS5@>] MH;1I#1)Y+E<\GSA-G6>Z6)\(QH= M+Q;V_CA>#.KJ9+J>4R_,\5[TR30V%P<)+XRW84V#!7HST[/)?TCT<6^YY$L9 M0^20WKS%S+`*J:V%7__[7W7(DSBE(@)LO'=_$Y;G);/VGJ@XVUE1=)/00F%] M_@WQIX70&G]%'RTW/N#@^G-6"*9PX7BD*QTQE#%BHP91:E'RG&/N1N>?6KQO MIY[0I9$F<%_`+NC9#$;UZ5OKDE7[S5WL2;1:N;0YD^6F7OW(F_MH&5^T9L;@ MW:A]6=3ZNL35I(RC[/.S-XV_0`Z`88&LR?.\2-;9&=W'^35H8VGZ:K;U(6[7 MR\-!\\S>V'+L:S@G@:1]YJ/:R3S>?`5Q2V7ZCD.+*&-'*]*?HV02CDU\9+ZO M6@5/"ND=T9IU?=DRQ'"=-A8'>M,HK2-.U/\^-Q4_\<,L!+B::J\)"DM=]/]]\0)9JX?1`C>P,?P M'4;SK=ZC\*J0ZV_[I&HIO,3YU[X-UP,IJ`JS-P-KH<7AZ/AN=@6U?)A\9)F:ZI4J&F.Z=19V&&JD5P M/K\\FAU00$1;,N91D;1EABS?17Z##GPA"`'%:*@%F&I)S5LO)4QJ9OXFT32` MWR,,^/2>5O$ULF/54/0;I$J:1);E`%N6R>V[R>D_;XD=.?V(___$7(`MS:7, M#,BMOD62G0->35J=A\R$AN52PTV>I^-!/(&C[(RE72LX64RTBM;>7)I2Y3:9 M0<]"CC]\=)3$\&Q$.F_.,RG@24XR!'PA@\SD]Z185!`1[@);7'Y/8=UZP0K. MG+D#[1-_:3E*>F/SD6D.W+F$5,C+#LC-`%_B.3W0-%5,+(B1<.W-?)T3?Q81 MR21W$KR0ON5=<2S,<7>D`&DK\)6AAM=T*)E*??9XW%:WQ>3:?S'VN^LGKC8BB29G#*A9_W8N^F#J/\%N!H7(7G/P]&"E''^TL)M M>FDA@P2&_Y5W1QM<#[.AD[FKX[2D^`2;*WY\&\#9RX5_OX>GQJ$M_F$[HN6# MU:1VN014Q2/Q8!R2V(`,-_+=5S*%B(AXA3HS2TE?(^Y7F_[=[/%*2@7K,RNN M0+-G4*\;3P.UN/$H>J\6E30PTFSF:EZ09'\Q*0ARA$F`[(88"DC```H'Y``9 MKH+7>Z54^Q=:]X86__(3MBKTAQR8G=3D,!S17MZV47>S;:#5;,7O9%7$O?&@ MWH2\!9I96\Y85(/3#^);#/$':9./\LRU%NV]P2(X/6F.$E[>`\+I&$`&&?KH MN'N>.GOEE>B_%20XA!7GCH4GT'_NTV?=2;MZ;:]8;$DAD!>4$Q@@!8+-$0&S M$Q_,E-N$_MF*_F5? M!CFS#%+_A/Q7*V$719N M"JNH\(OZ?@=<0N,I*\&BF$FJRDUHF,>//\\SQX7H&-N)A8\Z"Y"+0/5KX`)^ MLTT!G^C>"&4]WBGFW`^@YV.!14 MU??$PP$9#^@$8XI<@C_;=3ZLM39Y.WLC9^-HZCJS,]>W!'T)ZVF%/$@=9H2) M6:P-XH&`CC03'`@Y4%0%VZNJWW%F`^NC[T9>:*%8OW2@!]A@M6=*MP@0B(+`6J=-/R\JKXMS?N1](%+$G2=#G9+3I>A;&`EBN&'>=.C<[ M=VT!>X,TKKKS71OSG7B&X5KBHD;F%(=KX]%*U7)8?)#;`JUQ95Q>(RX6,BSD M,1',9%&.^'9>0U)?=`U7)+?D+<@%IRZ\2B%T?:ZEB(R*S$X\!V230#RK!R9& MS+.M9`Y_Z>T$YQHN''+=#8>UUK*#.P9,J%HT`@^[6#XV8P$9;+#43,2/HC`P MUJ>[0M[W_*)-KKC3E9^0>2#)G!?&;2%W.S\7F\?T62+T/U00YJJ))WJL5K"\4*$0X8DEXG5U#LX]Q',E6U>.)Z/ M:'.J^%T$K+Z*4&)3>`'#.W)=CW0UVZ=@D4;P<7LL[PG4<$[[6H)/N: M/^,O-?+0[Q94,2DU(<+5:OW6N,5([Y'@T*^B)HO.-?[ZBV!=K"]59B>:N>[% MFH[X4KR2XIP\:&U./)<$R?J"QKN8O,&5A^4W^`J.2MM\Q!JU*O(B;U[DY'02^T&$]Z?5] MP[M1REA4$]^I!.[<\2"-+)1*P0:+]M8-)1*J!8(,C<.M'K3PYC***1W%568: M(ED&_NNW="GX5_A?4RN`]-O\/U!+`P04````"`!N=FY!BQMAMJ`2```D&@$` M%0`<`'!F:&\M,C`Q,C`Y,S!?<')E+GAM;%54"0`#0/:C4$#VHU!U>`L``00E M#@``!#D!``#M75MOVSH2?E]@_X-/]F7WP74N;=,4[0%2.TYSFHN12].>Q:*0 M)=IF*Y,N)3EV?OV2NB22+,H219I2X+XT423.\)L+AT-R^.&/=KMU"A`@A@NL MUG#9@MU_N]/_M-JM+I[.;DS8.D,N_:OIPCF@S]`<$/H[_?O$=6?O.YV'AX=7 M)GW5,2$!#O:("1SVH-5N_]EB__[YCP^,2)<`1N)]ZY[2N<3SUM[KUM[1^[W= M][MO6W>WW=;^[MY^\!']PH;HU]!P0&LQM9'S<2=&;#$D]BM,QIW]W=V#3O3B M3O#F^P5[D'C_X^_HZ*CC__7I50=FO4B;W>M\NSB_,2=@:K0A+1QKY\\`N5;K`\$VN`:C MEL_Z>W5\_QA0KI`[`2XT#=M1THTT#36].D.4$7#CTI^GE)JTGJ3;[41F*)?]KN%, M^C9^D,;W4X.481G,7F(75&+.;T">[%ESNY49VI4)3P^X!K0K\Q0V4YVQ'C8] MIK/'R#I!+G279VB$R=0G68G+W(8[?X8"GM$!C+[D/SVG?"9Z`!8N0!:PHCZP M=J7ZS@`]RH:-S01EFXTVF$2$;6,([(\[M!T+((?:#:=!YWCHN&S@+FK:19OS M3:(4KY[3'AO&[,>34[HUAFEM")'TQ\B1X0S]@3+\L,/X[0#;=:(G?@_:NWOA M>/DO#H5(M.*<4CT`9_1'1RFWSU1BWCJED<[<8\J+@4;DR`#`+Q\0*J%42"4.=/ M#7+(MY5,S)/H)*$7PSUL\`XY,\"\&K!Z>&I`I`1[+K&$YN@409;Z)23!QRN4 MQFYH"#7HS'I]BOF\D/W]R(Z%U.G8<;C#D1P=2E&H"=(K8T<<[30H,45I4:9' M@!!@G0=`DE"I&.&XU6\R&LE3S+@9%81/ MW+KLF(3%O)]I8H_R=`U,0/FCSO<2N&'_E/C"/'KZPLNB`LV'2]Q<[E9GOKVJCQO&]M]\7]GZ098,3AP#:"%8J(3=]KJW&'N11UY=T*:FK2 M*^9C)R/@%!)JWR,(NAX!E*D^7+"?G%."'27!)Y]8@T29@YB,D+24%*]&(VB" M)\X+^C#2'^V@8\GLHZGF+CA5@=N9Q1- MW.7PIGEN7W#-2)HD!+S$4:!1"(P9?;'UIK4*?PD4S?]SZ&F?6183?CYFVJ:7 M$7M^P!V,1)<8F>K2`MF$:CP#78-0*+DWNC(XZE(W31!*A$$HA;?5[4=(%.?0 M&$(;NA"P=.V-B\U?$VQ3EAQFYC284+AYHC#MVNS'R95H<2A#F1]6SOR([+F( MLRFP\2+K\QJ;6UZG0S&\TY:`BS*[`V/)TKH;6&=*4=*[R2)'$[.6D](HZ=U: M03Q*[+D#:F7'(:;++Y:6'P^LC>?7(I[\)6?U9I=%1D^JIYS(,N&1D*.KG*"[ M&MIP[..ETN+64&R&V:V#3<8"KI`\>R&M:\I&E_X/56ZPX!-KAA1SP!*?>4L2 M(/42FQD!\PDVP:&N@4S"5+RB*2B)3]TK!Z";L3MNR%E[ MD>48FJS;H* MJ&B!V#(CNUQE=E[5,RIVB7K27B4EE8"CPIFCM`<4LSH\G4*7N0N6(>UBY$(T M!LA4)*L\C5=A2@SJ#3%&+,`$L_P)\-])1M+ M=&PHT17UEXM:UB,G>1[WH9,N0%:+PF3I:HC;.F7;.F7;.F7;.F6YMK*M4[:M M4]:\.F6VC1^8'^ECTL/>T!UY]NJI;Y5;S$HQ4!NURTV>E@15VX'=9(!/8YXK MXG?0\F/]`2!^]*@^K<>EK'T*5/282C$<=59R2O+H,^0<>^X$$_CX'$BKD_$* MQ6:8\CK8M*4ELA@[9EEDV-I$;+-<+:%`)1Q=K"J>#&C)B M5E0_+9-.$TP@&R`Y94ZK#30J!QC]4_$\Q3BLRE MI\W_%9%D/E(Z]T50,IA0KJZ!?]X@9$Z%]#B4-(5[1:3&PT;K]3EX!!S'/_NS M&EG+6B5/T:BM@UQ%0]]VAE.`J$';9\CQ"-O[IM"2>*1J[0*Y^$C9L%!U!+L: M1;-EI0-7C(R>M%NIP2H.BJXZ23XS$=?*9/-$H-8FE,)"SAZ"2MZ.!:/6%"+( MF';A?`->CTNRMJ/46JRD;"<0LZXH"%5J82M$-*?X"BIOPO16@=*3O5AA*%CG M/U>4#<\B$_#\X8]VN_7?^XNO!__[[S=SYBV^HS='UN/A?/Q]B>YZWL/I(3DZ M_++_\^YVZ=B'<_-QU_[+/?+FU\Y?M]\NP`5X.%]^/OK\Y>?;L[>SX=SL+7Z> M'Y__^FO6/_9^7;PE=_>?W;<8?OK5`V^ZY.1\9OQ-WAW]?KRYZR_.#E__]`XO M#B;C;X^/(S1Z_(5_/9X^GH+'GV#Q;O2[-Y@[^]-TWL#Q9 MWL'+GSU\9-X==OMX9`P^]\`5V34O?W=G-S>CQSF8CJW77[]]7UY/O[Y^>#>\ M/_I^/[2'TP/G\R<;FH^'`P/.E]_Z7Q8N-CY_G<^0,]H_`0OOD-R^1E]GDY_6 MZ>B\]W7Q]^M[Z^'CQ_^UNC?7[79]4T6YVE3AECSQ0\S^&!=P$9I:J3Q=SN:%@&NU\?$4)^#E;X\W1F: M`\<^/A`Z2NL0G&R`VXN,<(JTZM<6DT0'1\H M7<73(^51."5*D]"U/%O6RE+`R+N93-1#QC4FT0\54N,3T[V\SE'9N/!RD)(V M(1(>YJ+8M4][%=1L]"B;SSM&/X$1)B!XS[]HX0(B3*"[C#I.IX3)5H*Z+Q?` MG6#K>710$OELDOU&'*#9J#PE7J9707EI)T)S^@00&*DIF\8CI7T'21FUR$!* MRJUZH@,(<-4F8I($&B*J%"KR+MPK*:5/A@--=L>X9]O+'K0]][G87G2RLE2: MH52#-=E@G2FID0D*N1SV3LR-X&Y"[(B1Y3KZH/HK#+VP5=HW.37<.9]&W\ ML%/ZDL]U)]>BEE6=ELQIO_I1M^U121Z5^AZ57*]PQ4]*;@]*;@]*;@]*UJ$S MFSLH^>0_6.;D:8GXV'3A7.`2ZZ*-U49K,B=,Q3&1=VARFY+('09+:NGZ!,4F M;[\XMGYZ81+R%E\#$R,3VN")KUM,?V0]+&5KI1NM>3ZI/$C23CQ5/NZTX5-. M&8>;=,A55*UYQY]4G'K:[H;1(M8">V3*F"UO);A]I:"IL&50@MNE2DC8O9@]$/Q_AE:K3BM:4%M/5XN]"NAU:JFM`*`" MKEB*T?*YC*Z-CJT,;T;N680UC<#219\)JD2'+4OX`P)F!K0V*/4$15W35^GR M3N(HX-DY@I8DYI@:;MJ[9Y/6DQZ2+G8.KE+WZ,G2`7_?X3.7&S+W%:HO1/*K M:`ILBE(O]-`O*=U6NX;F2QG2TU`*[*!2/9I'`>?`6&X^?(^(ZLMMJHK?G^"4 M<8A8GJB)1XD_]VUCTD[3?3&3M15`=98NYW(8BSDV;><<\B_*XGD0RRA\+GG& M3KM/QIN>K4=$7X[05^`,17VD[X@-G\FP(.!F91X1?7DR?X(SRLUH.'$:+@,, M")Y#"UB?EG<.AT<>4D]*(.M)D<>L>KOSD+^*2<6 M:,P-FZGO`!#(#L0G9R,J%*$4_9KLN,\=%27=!,]>&$;Q=91DF%]Z9C8PH'4-1AX[ M`]W'I/1DC/=]K3UQ;L<%UCFJB^(YFQM4'6+HW99M=X"2'1< M0?>4=R/8!,`*\S3A8FC0"U6W:/#I:9WMEA!?/FBZBF(FUK)5F5J2A+9=O67- M+86,E*MJ:E"AXQ*[8*=L*>E82\\E$H+#9(,8TU>C<*)NV,_5$WK0,6WL>`3< MTCY\HA1^E2M$K8IXIY2[D[F_,4,HWEO? MRC9P>YF!6V']V49@=1DQMQ'8-@*KXY(=\4"N?TG1TUZ2 M'0%GD]=>J1&Z4$-E3=("\$?0VC48^SG2TC`B8QO)!J3CPL(8C9F[I>]513K2F94`1`3>)0_R%W,XQ MY<%B?/1M0X*6)YO3M&U0!-H4#K$M]>4S:XGV>L`Q"9SEE^,N#6^\U>:$(]F@ MQ+:QBX8CH3.B+1-V+[,%%E_`4IK/3C6K:\95P4NG@8EM(A>/M<,1^1K,6*UT M-&93(R\G\U`2]>S6&^12\E&*;1X7\S!!\U^Q[5$(R+(/;4"DH9]NMGDZOP), MO$*-T%`9M.LWUZ6!YQ@3:2XFV6@#X\`4*A'65::80;[; MIT\D^'=>PPT:6+G81*A7F'`FVPZDJ@3Y>-/-B>!SX(G`?_,<5'*2X!\ZK,VA MX0#_U_\#4$L#!!0````(`&YV;D%FKD4Z,`<``"2"?#K5[(Q8&,,)&V' M[J8/*4BZ5^?<H:<_/S^]UN93KF"%.7:8CK@9`.GT!U+_??_N@-BDS MI+8H@GNY3Y..0?889`O%;*:8.06];AD<9;)'OI&TF/`BUX?(AF!B6X07)WUF MX?/4RIYJY#UE`^THD\EIF'`!B8Y2\_7$M>-7&X)I8NH@3:Y`#.N!@6,.:H@R60*8S:J'D*&D.HXY\CK`,\S(4 MOH,UZW#DU+0F]T168PDYI5U\-SX.0S^=C]R3RR3P](K0^GY"&8^@>>4 M?]"BC@!8W\>57EKDPOLZYA_F29-MP`D4MMVP<$2IBO=!*"XFU_LC]2!F_ MM:4)$4,DL$3+=U`U:K%-Y*.7B`S>A7?Y,T;U-\EWE[Q.Y#!:R+!!YNBJBQBR M(6USNVF[6,(!-4'+49==Z4"JW"/0-;!<\R;PZP0N0SZL6?1Y@[*+Z=AB&=+T M^"6:*O]`;?"FZ>LT;5*!5C3TOFZKL"=2I0KFND6YRY#\TFQUJT`=KI>E3KT# M6C50JS=+S7*]U`"=;JE;O:DVNZ!]6^W(_TO=>JL9>ZC^U[3R7H._WM_A7W^2K/"OE/1X^][I1;^;$^RU@?1<$=W_*/W8<; M=(.>&]/KPO6GQ]/ZJ=,?ZY7)8Z/4&'UT:B5W='/*>O?7XI3BRU$%G919M>'` MO]E9X6G6Z=4F]?SQHYN_R0T'#[.92YDYL*:K&,WGPJ.YV..1LC>V`#Q]J'V:"`JO[\8.X>91%4TJC;\* M9]=F=C#2JW1P:7RNC>[8X/S\'U#NW*HFP(])[4PDMS,[%*33V/3VKA6]RT[U MT2Y5]?@<`[?[>X0^--P2T*5JCNJK.X M1(PJ$5A,Z\2DS/96^9HFKHCG&E(X$U4X<`BD1^"[!"L^_S]/X@KW8AM4]_PEF*AOZ<`NK8;2V:-T+OM^PHU%AV!/ M&(JXWZ/8#T9@]R(8R?W0#4`\$*N6`P@=SU!#EN`+7^FEKP6B/2.SWL?>)3A1 M*Q6:@@I-]O3U0%:[S/N!H:29@&<'1+$=X5W3)3!0FY^LAV'>H?9V/4\M7DA MUT(WQ'!8;MK-&D+\.Y25)%YX`>NS5$FRN\&"+F M-\?G1H?#(@';1CZ7D&-=GG,UU[*F%6RY,A>KD!$)GK<1\Q[>PV&X%]K5=XL] MRTO0(_\EJTL"^(20!$8U1NUY?2*#DOI3HP,[(G=&FE2"2L:CRX47L"Z]13HE M.K:0O./YCT^7RH]JH\.AO3?BR/M:1.XA)`/$ZV090._R?I"7HGW`)K->39TZ M&2/^2R1Y$M*D)`\YJ6$B3_A?@6X2TFUTVQ`;M\AT98DT:I0=%L--X!(N]JV5 M'N^RWLLO\A!LKW1)6^8\:M!:'@7+)FT73<2E1?71X03DAS%+K``=B0X]N7*@ M.O9*Z>$%9CO$1(9)W?W#(;D32N_2ZO7/_>ZA_YC\"U!+`0(>`Q0````(`&YV M;D%E25-]2A8``*BH```1`!@```````$```"D@0````!P9FAO+3(P,3(P.3,P M+GAM;%54!0`#0/:C4'5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`&YV;D%8 M1%TD;@H``%A]```5`!@```````$```"D@946``!P9FAO+3(P,3(P.3,P7V-A M;"YX;6Q55`4``T#VHU!U>`L``00E#@``!#D!``!02P$"'@,4````"`!N=FY! M^G3/,@42``!)#P$`%0`8```````!````I(%2(0``<&9H;RTR,#$R,#DS,%]D M968N>&UL550%``-`]J-0=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`;G9N M08]@J!;8(```]Y`Q0````(`&YV M;D&+&V&VH!(``"0:`0`5`!@```````$```"D@`L``00E#@``!#D!``!02P$"'@,4````"`!N M=FY!9JY%.C`'```G+0``$0`8```````!````I(&\9P``<&9H;RTR,#$R,#DS M,"YX`L``00E#@``!#D!``!02P4&``````8`!@`:`@`` &-V\````` ` end XML 16 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION
9 Months Ended
Sep. 30, 2012
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
NOTE 1 – BASIS OF FINANCIAL STATEMENT PRESENTATION

The accompanying unaudited condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”).  Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted in accordance with such rules and regulations.  The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements.  Although management believes the disclosures and information presented are adequate to make the information not misleading, it is suggested that these interim condensed financial statements be read in conjunction with the Company’s audited financial statements and notes thereto included in its Annual Report on Form 10-K for the year ended December 31, 2011.  Operating results for the nine-months ended September 30, 2012 are not necessarily indicative of the results to be expected for the year ending December 31, 2012.

XML 17 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 18 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE 2 - SUBSEQUENT EVENTS
9 Months Ended
Sep. 30, 2012
Subsequent Events [Text Block]
NOTE 2 – SUBSEQUENT EVENTS

In accordance with ASC 855-10 Company management reviewed all material events through the date of issuance and there are no material subsequent events to report.

XML 19 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Balance Sheets (Parentheticals) (USD $)
Sep. 30, 2012
Dec. 31, 2011
Allowance for doubtful accounts (in Dollars) $ 20,000 $ 20,000
Preferred stock, par value (in Dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in Shares) 5,000,000 5,000,000
Preferred stock, shares issued (in Shares) 0 0
Preferred stock, shares outstanding (in Shares) 0 0
Common stock par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in Shares) 50,000,000 50,000,000
Common stock, shares issued (in Shares) 802,424 802,424
Common stock, shares outstanding (in Shares) 802,424 802,424
XML 20 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document And Entity Information
9 Months Ended
Sep. 30, 2012
Nov. 09, 2012
Document and Entity Information [Abstract]    
Entity Registrant Name PACIFIC HEALTH CARE ORGANIZATION INC  
Document Type 10-Q  
Current Fiscal Year End Date --12-31  
Entity Common Stock, Shares Outstanding   802,424
Amendment Flag false  
Entity Central Index Key 0001138476  
Entity Current Reporting Status Yes  
Entity Voluntary Filers No  
Entity Filer Category Smaller Reporting Company  
Entity Well-known Seasoned Issuer No  
Document Period End Date Sep. 30, 2012  
Document Fiscal Year Focus 2012  
Document Fiscal Period Focus Q3  
XML 21 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Operations (Unaudited) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Revenues:        
HCO fees $ 301,077 $ 205,362 $ 691,574 $ 565,831
MPN fees 205,238 171,092 569,584 455,761
Other 820,486 487,943 2,255,011 1,006,308
Total revenues 1,326,801 864,397 3,516,169 2,027,900
Expenses:        
Depreciation & amortization 7,153 3,903 19,605 9,691
Consulting fees 143,326 93,946 354,019 279,173
Salaries & wages 440,890 363,206 1,236,088 791,842
Professional fees 77,558 49,428 195,833 146,380
Insurance 54,854 40,766 152,761 107,947
Outsource service fees 114,550 57,199 259,972 120,825
Data maintenance 31,285 19,370 51,969 36,463
General & administrative 143,285 107,987 356,349 301,512
Total expenses 1,012,901 735,805 2,626,596 1,793,833
Income from operations 313,900 128,592 889,573 234,067
Other income (expense):        
Loss on disposal of assets 0 0 0 (1,564)
Interest income 170 224 551 760
Rental income 250 0 1,750 0
Interest (expense) (173) (285) (604) (934)
Total other income (expense) 247 (61) 1,697 (1,738)
Income before taxes 314,147 128,531 891,270 232,329
Income tax provision 127,574 53,671 361,944 85,182
Net income $ 186,573 $ 74,860 $ 529,326 $ 147,147
Basic and fully diluted earnings per share:        
Earnings per share amount (in Dollars per share) $ 0.23 $ 0.09 $ 0.66 $ 0.18
Weighted average common shares outstanding (in Shares) 802,424 802,424 802,424 802,424
XML 22 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Cash flows from operating activities:    
Net income $ 529,326 $ 147,147
Adjustments to reconcile net income to net cash:    
Depreciation and amortization 19,604 9,691
Loss on disposition of assets 0 1,564
Changes in operating assets & liabilities    
(Increase) in accounts receivable (835,603) (274,120)
Decrease in deferred tax asset 0 5,400
(Increase) in prepaid income tax (61,511) (108,800)
Decrease in income tax receivable 0 35,100
Decrease (increase) in commission draw 29,350 (5,760)
Decrease in prepaid expenses 4,820 26,203
(Decrease) increase in accounts payable (53,713) 30,714
Increase in accrued expenses 113,446 91,969
Increase in income tax payable 361,944 84,854
Increase in deferred rent expense 3,129 18,414
(Decrease) in unearned revenue (3,046) (4,720)
Net cash provided by operating activities 107,746 57,656
Cash flows from investing activities    
Purchases of furniture & equipment (63,551) (50,443)
Net cash used by investing activities (63,551) (50,443)
Cash flows from financing activities    
Payment of obligation under capital lease (4,900) (4,570)
Net cash provided by (used in) financing activities (4,900) (4,570)
Increase in cash 39,295 2,643
Cash at beginning of period 368,459 349,552
Cash at end of period 407,754 352,195
Cash paid (refunded) for:    
Interest 604 649
Taxes refunded 0 (38,718)
Taxes paid $ 61,511 $ 107,346
XML 23 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 9 102 1 false 0 0 false 3 false false R1.htm 000 - Disclosure - Document And Entity Information Sheet http://www.pacifichealthcareorganization.com/role/DocumentAndEntityInformation Document And Entity Information true false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.pacifichealthcareorganization.com/role/ConsolidatedBalanceSheet Condensed Consolidated Balance Sheets false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://www.pacifichealthcareorganization.com/role/ConsolidatedBalanceSheet_Parentheticals Condensed Consolidated Balance Sheets (Parentheticals) false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://www.pacifichealthcareorganization.com/role/ConsolidatedIncomeStatement Condensed Consolidated Statements of Operations (Unaudited) false false R5.htm 004 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.pacifichealthcareorganization.com/role/ConsolidatedCashFlow Condensed Consolidated Statements of Cash Flows (Unaudited) false false R6.htm 005 - Disclosure - NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION Sheet http://www.pacifichealthcareorganization.com/role/Note NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION false false R7.htm 006 - Disclosure - NOTE 2 - SUBSEQUENT EVENTS Sheet http://www.pacifichealthcareorganization.com/role/Note0 NOTE 2 - SUBSEQUENT EVENTS false false All Reports Book All Reports Process Flow-Through: 001 - Statement - Condensed Consolidated Balance Sheets Process Flow-Through: Removing column 'Sep. 30, 2011' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: 002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) Process Flow-Through: 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Process Flow-Through: 004 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) pfho-20120930.xml pfho-20120930.xsd pfho-20120930_cal.xml pfho-20120930_def.xml pfho-20120930_lab.xml pfho-20120930_pre.xml true true